{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T22:47:29Z","timestamp":1784587649655,"version":"3.55.0"},"publisher-location":"Cham","reference-count":318,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030926151","type":"print"},{"value":"9783030926168","type":"electronic"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/978-3-030-92616-8_3","type":"book-chapter","created":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T07:02:41Z","timestamp":1647241361000},"page":"61-103","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Immunogenetics of Vitiligo: An Approach Toward Revealing the Secret of Depigmentation"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8497-0765","authenticated-orcid":false,"given":"Mitesh","family":"Dwivedi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naresh C.","family":"Laddha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasheedunnisa","family":"Begum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,15]]},"reference":[{"key":"3_CR2","doi-asserted-by":"crossref","unstructured":"Abanmi A, Al Harthi F, Al Baqami R, Al Assaf S, Zouman A et al (2006) Association of HLA loci alleles and antigens in Saudi patients with vitiligo. Arch Dermatol Res 7:347\u2013352","DOI":"10.1007\/s00403-006-0699-4"},{"key":"3_CR1","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1155\/2008\/210609","volume":"1","author":"A Abanmi","year":"2008","unstructured":"Abanmi A, Al Harthi F, Zouman A, Kudwah A, Jamal MA et al (2008) Association of interleukin-10 gene promoter polymorphisms in Saudi patients with vitiligo. Dis Markers 1:51\u201357","journal-title":"Dis Markers"},{"key":"3_CR3","unstructured":"Abdullah GA, Yassin M, Alhamamy H, Mahdi BM (2015) The association between human leukocyte antigen-DRB1 and vitiligo"},{"key":"3_CR4","first-page":"183","volume":"2","author":"S Agarwal","year":"2017","unstructured":"Agarwal S, Changotra H (2017) Association of protein tyrosine phosphatase, non-receptor type 22 +1858C\u2192T polymorphism and susceptibility to vitiligo: systematic review and meta-analysis. Indian J Dermatol Venereol Leprol 2:183\u2013189","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"3_CR5","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/jid.2014.529","volume":"4","author":"P Agarwal","year":"2015","unstructured":"Agarwal P, Rashighi M, Essien KI, Richmond JM, Randall L et al (2015) Simvastatin prevents and reverses depigmentation in a mouse model of vitiligo. J Invest Dermatol 4:1080\u20131088","journal-title":"J Invest Dermatol"},{"key":"3_CR81","doi-asserted-by":"crossref","unstructured":"Akay BN, Bozkir M, Anadolu Y, Gullu S (2010) Epidemiology of vitiligo, associated autoimmune diseases and audiological abnormalities: ankara study of 80 patients in Turkey. J Eur Acad Dermatol Venereol 10:1144\u20131150","DOI":"10.1111\/j.1468-3083.2010.03605.x"},{"key":"3_CR6","doi-asserted-by":"crossref","unstructured":"Akbas H, Dertlioglu SB, Dilmec F, Atay AE (2014) Lack of association between PTPN22 Gene +1858 C>T polymorphism and susceptibility to generalized vitiligo in a Turkish population. Ann Dermatol 1:88\u201391","DOI":"10.5021\/ad.2014.26.1.88"},{"key":"3_CR7","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s00403-005-0585-5","volume":"2","author":"S Akhtar","year":"2005","unstructured":"Akhtar S, Gavalas NG, Gawkrodger DJ, Watson PF, Weetman AP et al (2005) An insertion\/deletion polymorphism in the gene encoding angiotensin converting enzyme is not associated with generalised vitiligo in an English population. Arch Dermatol Res 2:94\u201398","journal-title":"Arch Dermatol Res"},{"key":"3_CR8","doi-asserted-by":"crossref","unstructured":"Al Badri AM, Foulis AK, Todd PM, Garioch JJ, Gudgeon JE et al (1993) Abnormal expression of MHC class II and ICAM-1 by melanocytes in vitiligo. J Pathol 2:203\u2013206","DOI":"10.1002\/path.1711690205"},{"key":"3_CR9","doi-asserted-by":"crossref","unstructured":"Ala Y, Pasha MK, Rao RN, Komaravalli PL, Jahan P (2015) Association of IFN-\u03b3:\u2009IL-10 cytokine ratio with nonsegmental vitiligo pathogenesis. Zhou X-J, ed. Autoimmune Dis 423490","DOI":"10.1155\/2015\/423490"},{"key":"3_CR10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1744-313X.1995.tb00232.x","volume":"2","author":"AL\u2010Fouzan AA, Al\u2010Arbash M, Fouad F,","year":"1995","unstructured":"AL\u2010Fouzan AA, Al\u2010Arbash M, Fouad F, Kaaba SA, Mousa MA et al (1995) Study of HLA class I\/IL and T lymphocyte subsets in Kuwaiti vitiligo patients. Eur J Immunogenet 2:209\u2013213","journal-title":"Eur J Immunogenet"},{"key":"3_CR11","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.4238\/2013.July.8.1","volume":"3","author":"Al-Harthi F, Zouman A, Arfin M, Tar","year":"2013","unstructured":"Al-Harthi F, Zouman A, Arfin M, Tariq M, Al-Asmari A (2013) Tumor necrosis factor-\u03b1 and -\u03b2 genetic polymorphisms as a risk factor in Saudi patients with vitiligo. Genet Mol Res 3:2196\u20132204","journal-title":"Genet Mol Res"},{"key":"3_CR12","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.jaad.2010.11.061","volume":"3","author":"A Alikhan","year":"2011","unstructured":"Alikhan A, Felsten LM, Daly M, Petronic-Rosic V (2011) Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. J Am Acad Dermatol 3:473\u2013491","journal-title":"J Am Acad Dermatol"},{"key":"3_CR13","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00403-010-1064-1","volume":"8","author":"A Alkhateeb","year":"2010","unstructured":"Alkhateeb A, Qarqaz F (2010) Genetic association of NALP1 with generalized vitiligo in Jordanian Arabs. Arch Dermatol Res 8:631\u2013634","journal-title":"Arch Dermatol Res"},{"key":"3_CR14","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1093\/hmg\/11.6.661","volume":"6","author":"A Alkhateeb","year":"2002","unstructured":"Alkhateeb A, Stetler GL, Old W, Talbert J, Uhlhorn C et al (2002) Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-p32.2. Hum Mol Genet 6:661\u2013667","journal-title":"Hum Mol Genet"},{"key":"3_CR15","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1034\/j.1600-0749.2003.00032.x","volume":"3","author":"A Alkhateeb","year":"2003","unstructured":"Alkhateeb A, Fain PR, Thody A, Bennett DC, Spritz RA (2003) Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res 3:208\u2013214","journal-title":"Pigment Cell Res"},{"key":"3_CR16","first-page":"701","volume":"6","author":"A Alkhateeb","year":"2010","unstructured":"Alkhateeb A, Al-Dain Marzouka N, Qarqaz F (2010) SMOC2 gene variant and the risk of vitiligo in Jordanian Arabs. Eur J Dermatol 6:701\u2013704","journal-title":"Eur J Dermatol"},{"key":"3_CR17","doi-asserted-by":"crossref","unstructured":"Alkhateeb A, Marzouka NA, Tashtoush R (2013) Variants in PTPN22 and SMOC2 genes and the risk of thyroid disease in the Jordanian Arab population. Endocrine 3:702\u2013709","DOI":"10.1007\/s12020-013-9908-z"},{"key":"3_CR18","doi-asserted-by":"crossref","unstructured":"Almasi-Nasrabadi M, Amoli MM, Robati RM, Rajabi F, Ghalamkarpour F et al (2019) CDH1 and DDR1 common variants confer risk to vitiligo and autoimmune comorbidities. Gene 17\u201322","DOI":"10.1016\/j.gene.2019.03.026"},{"key":"3_CR19","first-page":"402","volume":"3","author":"H Al-Shobaili","year":"2013","unstructured":"Al-Shobaili H, Settin A, Alzolibani A, Al Robaee A, Salem T et al (2013) Interleukin-4 (-590 C>T) and interleukin-4 receptor (Q551R A>G) gene polymorphisms in Saudi patients with vitiligo. Eur J Dermatol 3:402\u2013404","journal-title":"Eur J Dermatol"},{"key":"3_CR20","first-page":"1183","volume":"1709","author":"W Amos","year":"2011","unstructured":"Amos W, Driscoll E, Hoffman JI (2011) Candidate genes versus genome-wide associations: which are better for detecting genetic susceptibility to infectious disease? Proc Biol Sci 1709:1183\u20131188","journal-title":"Proc Biol Sci"},{"key":"3_CR21","first-page":"408","volume":"4","author":"Ando I, Chi HI, Nakagawa H, Otsuka","year":"1993","unstructured":"Ando I, Chi HI, Nakagawa H, Otsuka F (1993) Difference in clinical features and HLA antigens between familial and non-familial vitiligo of non-segmental type. Br J Dermatol 4:408\u2013410","journal-title":"Br J Dermatol"},{"key":"3_CR22","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s00439-002-0687-5","volume":"4","author":"M Arcos-Burgos","year":"2002","unstructured":"Arcos-Burgos M, Parodi E, Salgar M, Bedoya E, Builes J et al (2002) Vitiligo: complex segregation and linkage disequilibrium analyses with respect to microsatellite loci spanning the HLA. Hum Genet 4:334\u2013342","journal-title":"Hum Genet"},{"key":"3_CR23","first-page":"1","volume":"4","author":"A Babalghith","year":"2014","unstructured":"Babalghith A (2014) TAP1 and LMP7 gene polymorphisms associated with vitiligo in Saudi community. Int J Curr Microbiol App Sci 4:1\u20139","journal-title":"Int J Curr Microbiol App Sci"},{"key":"3_CR24","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1089\/gtmb.2014.0326","volume":"5","author":"DI Badran","year":"2015","unstructured":"Badran DI, Nada H, Hassan R (2015) Association of angiotensin-converting enzyme ACE gene polymorphism with ACE activity and susceptibility to vitiligo in Egyptian population. Genet Test Mol Biomarkers 5:258\u2013263","journal-title":"Genet Test Mol Biomarkers"},{"key":"3_CR25","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1111\/j.1468-3083.2008.02681.x","volume":"8","author":"PY Basak","year":"2008","unstructured":"Basak PY, Adiloglu AK, Koc IG, Tas T, Akkaya VB (2008) Evaluation of activatory and inhibitory natural killer cell receptors in non-segmental vitiligo: a flow cytometric study. J Eur Acad Dermatol Venereol 8:970\u2013976","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3_CR26","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.coi.2012.11.004","volume":"1","author":"M Basler","year":"2013","unstructured":"Basler M, Kirk CJ, Groettrup M (2013) The immunoproteasome in antigen processing and other immunological functions. Curr Opin Immunol 1:74\u201380","journal-title":"Curr Opin Immunol"},{"key":"3_CR27","first-page":"615","volume":"16","author":"PN Behl","year":"1955","unstructured":"Behl PN (1955) Leucoderma and its treatment with Ammi majus. J Indian Med Assoc 16:615\u2013618","journal-title":"J Indian Med Assoc"},{"key":"3_CR28","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1016\/j.jid.2018.02.025","volume":"8","author":"S Ben","year":"2018","unstructured":"Ben S, Jin Y, Santorico SA, Spritz RA (2018) Genome-Wide Association of PVT1 with Vitiligo. J Invest Dermatol 8:1884\u20131886","journal-title":"J Invest Dermatol"},{"key":"3_CR29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1755-148X.2011.00920.x","volume":"1","author":"Ben Ahmed M, Zaraa I, Rekik R, Elbe","year":"2012","unstructured":"Ben Ahmed M, Zaraa I, Rekik R, Elbeldi\u2010Ferchiou A, Kourda N et al (2012) Functional defects of peripheral regulatory T lymphocytes in patients with progressive vitiligo. Pigment Cell Melanoma Res 1:99\u2013109","journal-title":"Pigment Cell Melanoma Res"},{"key":"3_CR30","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/0923-1811(92)90017-6","volume":"3","author":"PS Bhatia","year":"1992","unstructured":"Bhatia PS, Mohan L, Pandey ON, Singh KK, Arora SK et al (1992) Genetic nature of vitiligo. J Dermatol Sci 3:180\u2013184","journal-title":"J Dermatol Sci"},{"key":"3_CR31","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1002\/med.20146","volume":"3","author":"SA Birlea","year":"2009","unstructured":"Birlea SA, Costin GE, Norris DA (2009a) New insights on therapy with vitamin D analogs targeting the intracellular pathways that control repigmentation in human vitiligo. Med Res Rev 3:514\u2013546","journal-title":"Med Res Rev"},{"key":"3_CR35","doi-asserted-by":"crossref","unstructured":"Birlea SA, LaBerge GS, Procopciuc LM, Fain PR, Spritz RA (2009b) CTLA4 and generalized vitiligo: two genetic association studies and a meta-analysis of published data. Pigment Cell Melanoma Res 2:230\u2013234","DOI":"10.1111\/j.1755-148X.2009.00543.x"},{"key":"3_CR32","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/jid.2009.347","volume":"3","author":"SA Birlea","year":"2010","unstructured":"Birlea SA, Gowan K, Fain PR, Spritz RA (2010) Genome-wide association study of generalized vitiligo in an isolated European founder population identifies SMOC2, in close proximity to IDDM8. J Invest Dermatol 3:798\u2013803","journal-title":"J Invest Dermatol"},{"key":"3_CR34","doi-asserted-by":"crossref","unstructured":"Birlea SA, Jin Y, Bennett DC, Herbstman DM, Wallace MR B et al (2011) Comprehensive association analysis of candidate genes for generalized vitiligo supports XBP1, FOXP3, and TSLP. J Invest Dermatol 2:371\u2013381","DOI":"10.1038\/jid.2010.337"},{"key":"3_CR33","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/jid.2012.501","volume":"5","author":"SA Birlea","year":"2013","unstructured":"Birlea SA, Ahmad FJ, Uddin RM, Ahmad S, Pal SS et al (2013) Association of generalized vitiligo with MHC class II loci in patients from the Indian subcontinent. J Invest Dermatol 5:1369\u20131372","journal-title":"J Invest Dermatol"},{"key":"3_CR36","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1600-0749.2004.00196.x","volume":"1","author":"A Blomhoff","year":"2005","unstructured":"Blomhoff A, Kemp EH, Gawkrodger DJ, Weetman AP, Husebye ES et al (2005) CTLA4 polymorphisms are associated with vitiligo, in patients with concomitant autoimmune diseases. Pigment Cell Res 1:55\u201358","journal-title":"Pigment Cell Res"},{"key":"3_CR37","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/j.1600-0625.2008.00826.x","volume":"7","author":"RE Boissy","year":"2009","unstructured":"Boissy RE, Spritz RA (2009) Frontiers and controversies in the pathobiology of vitiligo: separating the wheat from the chaff. Exp Dermatol 7:583\u2013585","journal-title":"Exp Dermatol"},{"key":"3_CR38","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jid.2017.08.038","volume":"2","author":"K Boniface","year":"2018","unstructured":"Boniface K, Jacquemin C, Darrigade A-S, Dessarthe B, Martins C et al (2018) Vitiligo skin is imprinted with resident memory CD8 T cells expressing CXCR3. J Invest Dermatol 2:355\u2013364","journal-title":"J Invest Dermatol"},{"key":"3_CR39","first-page":"23","volume":"1\u20132","author":"M Buc","year":"1996","unstructured":"Buc M, Busov\u00e1 B, Hegyi E, Kolib\u00e1sov\u00e1 K (1996) Vitiligo is associated with HLA-A2 and HLA-Dw7 in the Slovak populations. Folia Biol (praha) 1\u20132:23\u201325","journal-title":"Folia Biol (praha)"},{"key":"3_CR40","first-page":"13","volume":"1","author":"M Buc","year":"1998","unstructured":"Buc M, Fazekasov\u00e1 H, Cechov\u00e1 E, Hegyi E, Kolib\u00e1sov\u00e1 K et al (1998) Occurrence rates of HLA-DRB1, HLA-DQB1, and HLA-DPB1 alleles in patients suffering from vitiligo. Eur J Dermatol 1:13\u201315","journal-title":"Eur J Dermatol"},{"key":"3_CR41","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.1016\/j.febslet.2011.04.032","volume":"23","author":"GL Burn","year":"2011","unstructured":"Burn GL, Svensson L, Sanchez-Blanco C, Saini M, Cope AP (2011) Why is PTPN22 a good candidate susceptibility gene for autoimmune disease? FEBS Lett 23:3689\u20133698","journal-title":"FEBS Lett"},{"key":"3_CR42","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.4049\/jimmunol.1302139","volume":"4","author":"KT Byrne","year":"2014","unstructured":"Byrne KT, Zhang P, Steinberg SM, Turk MJ (2014) Autoimmune vitiligo does not require the ongoing priming of naive CD8 T cells for disease progression or associated protection against melanoma. J Immunol 4:1433\u20131439","journal-title":"J Immunol"},{"key":"3_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1346-8138.1985.tb01532.x","volume":"1","author":"JC Bystryn","year":"1985","unstructured":"Bystryn JC, Naughton GK (1985) The significance of vitiligo antibodies. J Dermatol 1:1\u20139","journal-title":"J Dermatol"},{"key":"3_CR44","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/sj.gene.6364243","volume":"7","author":"I Cant\u00f3n","year":"2005","unstructured":"Cant\u00f3n I, Akhtar S, Gavalas NG, Gawkrodger DJ, Blomhoff A et al (2005) A single-nucleotide polymorphism in the gene encoding lymphoid protein tyrosine phosphatase (PTPN22) confers susceptibility to generalised vitiligo. Genes Immun 7:584\u2013587","journal-title":"Genes Immun"},{"key":"3_CR45","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/sj.gene.6364016","volume":"7","author":"CB Casp","year":"2003","unstructured":"Casp CB, She JX, McCormack WT (2003) Genes of the LMP\/TAP cluster are associated with the human autoimmune disease vitiligo. Genes Immun 7:492\u2013499","journal-title":"Genes Immun"},{"key":"3_CR46","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1073\/pnas.1523482113","volume":"5","author":"G Cavalli","year":"2016","unstructured":"Cavalli G, Hayashi M, Jin Y, Yorgov D, Santorico SA et al (2016) MHC class II super-enhancer increases surface expression of HLA-DR and HLA-DQ and affects cytokine production in autoimmune vitiligo. Proc Natl Acad Sci USA 5:1363\u20131368","journal-title":"Proc Natl Acad Sci USA"},{"key":"3_CR47","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1093\/jmcb\/mjp004","volume":"1","author":"W Chen","year":"2010","unstructured":"Chen W, Konkel JE (2010) TGF-beta and \u201cadaptive\u201d Foxp3(+) regulatory T cells. J Mol Cell Biol 1:30\u201336","journal-title":"J Mol Cell Biol"},{"key":"3_CR48","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1086\/430279","volume":"6","author":"JJ Chen","year":"2005","unstructured":"Chen JJ, Huang W, Gui JP, Yang S, Zhou FS et al (2005) A novel linkage to generalized vitiligo on 4q13-q21 identified in a genomewide linkage analysis of Chinese families. Am J Hum Genet 6:1057\u20131065","journal-title":"Am J Hum Genet"},{"key":"3_CR49","doi-asserted-by":"publisher","first-page":"16400","DOI":"10.1073\/pnas.0607854103","volume":"44","author":"Z Chen","year":"2006","unstructured":"Chen Z, Stockton J, Mathis D, Benoist C (2006) Modeling CTLA4-linked autoimmunity with RNA interference in mice. Proc Natl Acad Sci USA 44:16400\u201316405","journal-title":"Proc Natl Acad Sci USA"},{"key":"3_CR50","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1111\/j.1600-0625.2009.00897.x","volume":"12","author":"KA Cheong","year":"2009","unstructured":"Cheong KA, Chae SC, Kim YS, Kwon HB, Chung HT et al (2009) Association of thymic stromal lymphopoietin gene -847C>T polymorphism in generalized vitiligo. Exp Dermatol 12:1073\u20131075","journal-title":"Exp Dermatol"},{"key":"3_CR51","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3346\/jkms.2013.28.5.775","volume":"5","author":"KA Cheong","year":"2013","unstructured":"Cheong KA, Kim NH, Noh M, Lee AY (2013) Three new single nucleotide polymorphisms identified by a genome-wide association study in Korean patients with vitiligo. J Korean Med Sci 5:775\u2013779","journal-title":"J Korean Med Sci"},{"key":"3_CR52","first-page":"713","volume":"7289","author":"N Craddock","year":"2010","unstructured":"Craddock N, Hurles ME, Cardin N, Pearson RD, Plagnol V et al (2010) Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature 7289:713","journal-title":"Nature"},{"key":"3_CR53","unstructured":"Dai X (1990) A study on the association of HLA antigens with vitiligo. Chin J Dermatol 31\u201333"},{"key":"3_CR54","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/bjd.15391","volume":"2","author":"P Dani","year":"2018","unstructured":"Dani P, Patnaik N, Singh A, Jaiswal A, Agrawal B et al (2018) Association and expression of the antigen-processing gene PSMB8, coding for low-molecular-mass protease 7, with vitiligo in North India: case-control study. Br J Dermatol 2:482\u2013491","journal-title":"Br J Dermatol"},{"key":"3_CR55","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/gepi.1370020303","volume":"3","author":"SK Das","year":"1985","unstructured":"Das SK, Majumder PP, Majumdar TK, Haldar B (1985) Studies on vitiligo. II Familial aggregation and genetics. Genet Epidemiol 3:255\u2013262","journal-title":"Genet Epidemiol"},{"key":"3_CR56","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1600-0749.2004.00145.x","volume":"3","author":"De Vijlder HC, Westerhof W, Schreud","year":"2004","unstructured":"De Vijlder HC, Westerhof W, Schreuder GMT, De Lange P, Claas FH (2004) Difference in pathogenesis between vitiligo vulgaris and halo nevi associated with vitiligo is supported by an HLA association study. Pigment Cell Res 3:270\u2013274","journal-title":"Pigment Cell Res"},{"key":"3_CR57","doi-asserted-by":"publisher","first-page":"267","DOI":"10.4049\/jimmunol.171.1.267","volume":"1","author":"DK Deb","year":"2003","unstructured":"Deb DK, Sassano A, Lekmine F, Majchrzak B, Verma A et al (2003) Activation of protein kinase C delta by IFN-gamma. J Immunol 1:267\u2013273","journal-title":"J Immunol"},{"key":"3_CR58","first-page":"9","volume":"1","author":"F Deeba","year":"2009","unstructured":"Deeba F, Jamil K, Rabbani S, Waheed MA, Rao H (2009) Association of angiotensin converting enzyme gene I\/D polymorphism with vitiligo in South Indian population. Int J Med Med Sci 1:9\u201312","journal-title":"Int J Med Med Sci"},{"key":"3_CR59","first-page":"29","volume":"1","author":"F Deeba","year":"2010","unstructured":"Deeba F, Syed R, Quareen J, Waheed MA, Jamil K et al (2010) CTLA-4 A49G gene polymorphism is not associated with vitiligo in South Indian population. Indian J Dermatol 1:29\u201332","journal-title":"Indian J Dermatol"},{"key":"3_CR60","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.immuni.2006.06.011","volume":"2","author":"S Devadas","year":"2006","unstructured":"Devadas S, Das J, Liu C, Zhang L, Roberts AI et al (2006) Granzyme B is critical for T cell receptor-induced cell death of type 2 helper T cells. Immunity 2:237\u2013247","journal-title":"Immunity"},{"key":"3_CR61","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12864-017-3510-3","volume":"1","author":"R Dey-Rao","year":"2017","unstructured":"Dey-Rao R, Sinha AA (2017) Vitiligo blood transcriptomics provides new insights into disease mechanisms and identifies potential novel therapeutic targets. BMC Genomics 1:109","journal-title":"BMC Genomics"},{"key":"3_CR62","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2340\/00015555-0999","volume":"2","author":"K Douroudis","year":"2011","unstructured":"Douroudis K, Kingo K, Karelson M, Silm H, Reimann E et al (2011) The PRO2268 gene as a novel susceptibility locus for vitiligo. Acta Derm Venereol 2:189\u2013191","journal-title":"Acta Derm Venereol"},{"key":"3_CR63","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1001\/archderm.1990.01670250062009","volume":"1","author":"GM Dunston","year":"1990","unstructured":"Dunston GM, Halder RM (1990) Vitiligo is associated with HLA-DR4 in black patients. A preliminary report. Arch Dermatol 1:56\u201360","journal-title":"Arch Dermatol"},{"key":"3_CR64","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/j.1755-148X.2008.00462.x","volume":"3","author":"M Dwivedi","year":"2008","unstructured":"Dwivedi M, Laddha NC, Shajil EM, Shah BJ, Begum R (2008) The ACE gene I\/ D polymorphism is not associated with generalized vitiligo susceptibility in Gujarat population. Pigment Cell Melanoma Res 3:407\u2013408","journal-title":"Pigment Cell Melanoma Res"},{"key":"3_CR65","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1365-2133.2009.09140.x","volume":"1","author":"M Dwivedi","year":"2009","unstructured":"Dwivedi M, Gupta K, Gulla KC, Laddha NC, Hajela K et al (2009) Lack of genetic association of promoter and structural variants of mannan-binding lectin (MBL2) gene with susceptibility to generalized vitiligo. Br J Dermatol 1:63\u201369","journal-title":"Br J Dermatol"},{"key":"3_CR73","doi-asserted-by":"crossref","unstructured":"Dwivedi M, Laddha NC, Imran M, Shah BJ, Begum R (2011) Cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) in isolated vitiligo: a genotype-phenotype correlation. Pigment Cell Melanoma Res 4:737\u2013740","DOI":"10.1111\/j.1755-148X.2011.00892.x"},{"key":"3_CR66","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/pcmr.12105","volume":"4","author":"M Dwivedi","year":"2013","unstructured":"Dwivedi M, Laddha NC, Arora P, Marfatia YS, Begum R (2013a) Decreased regulatory T-cells and CD4+\/CD8+ ratio correlate with disease onset and progression in patients with generalized vitiligo. Pigment Cell Melanoma Res 4:586\u2013591","journal-title":"Pigment Cell Melanoma Res"},{"key":"3_CR67","first-page":"921","volume":"1","author":"M Dwivedi","year":"2013","unstructured":"Dwivedi M, Laddha NC, Imran M, Shah BJ, Begum R et al (2013b) Complete sequence and gene map of a human major histocompatibility complex. The MHC sequencing consortium. Pigment Cell Melanoma Res 1:921\u2013923","journal-title":"Pigment Cell Melanoma Res"},{"key":"3_CR68","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jdermsci.2013.04.026","volume":"3","author":"M Dwivedi","year":"2013","unstructured":"Dwivedi M, Laddha NC, Begum R (2013c) Correlation of increased MYG1 expression and its promoter polymorphism with disease progression and higher susceptibility in vitiligo patients. J Dermatol Sci 3:195\u2013202","journal-title":"J Dermatol Sci"},{"key":"3_CR69","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1089\/jir.2012.0171","volume":"11","author":"M Dwivedi","year":"2013","unstructured":"Dwivedi M, Laddha NC, Shah K, Shah BJ, Begum R (2013d) Involvement of interferon-gamma genetic variants and intercellular adhesion molecule-1 in onset and progression of generalized Vitiligo. J Interf Cytokine Res 11:646\u2013659","journal-title":"J Interf Cytokine Res"},{"key":"3_CR71","doi-asserted-by":"crossref","unstructured":"Dwivedi M, Laddha NC, Shah K, Shah BJ, Begum R (2013e) Involvement of interferon-gamma genetic variants and intercellular adhesion molecule-1 in onset and progression of generalized vitiligo. J Interferon Cytokine Res 33(11):646\u2013659","DOI":"10.1089\/jir.2012.0171"},{"key":"3_CR74","doi-asserted-by":"crossref","unstructured":"Dwivedi M, Laddha NC, Mansuri MS, Marfatia YS, Begum R (2013f) Association of NLRP1 genetic variants and mRNA overexpression with generalized vitiligo and disease activity in a Gujarat population. Br J Dermatol 5:1114\u20131125","DOI":"10.1111\/bjd.12467"},{"key":"3_CR72","doi-asserted-by":"crossref","unstructured":"Dwivedi M, Kemp EH, Laddha NC, Mansuri MS Weetman AP et al (2015) Regulatory T cells in vitiligo: implications for pathogenesis and therapeutics. Autoimmun Rev 1:49\u201356","DOI":"10.1016\/j.autrev.2014.10.002"},{"key":"3_CR70","first-page":"1","volume":"8","author":"M Dwivedi","year":"2018","unstructured":"Dwivedi M, Laddha N, Begum R (2018) Viral causes of vitiligo: a new perspective for vitiligo pathogenesis. Viral Immunol 8:1\u20134","journal-title":"Viral Immunol"},{"key":"3_CR75","unstructured":"Eldin N, Teama S, Amro K, Farag H, Eldin SMN et al (2006) Polymorphisms of TAP1\/LMP7 loci in Egyptian patients with vitiligo. undefined"},{"key":"3_CR76","doi-asserted-by":"crossref","unstructured":"Elgendy A, Alshawadfy E, Ali EA, Wadea N, Khalil K et al (2016) Association of HLA Class I and II antigens with vitiligo in Egyptian population","DOI":"10.21767\/2572-5475.10011"},{"key":"3_CR77","doi-asserted-by":"crossref","unstructured":"Elhawary NA, Bogari N, Jiffri EH, Rashad M, Fatani A et al (2014) Transporter TAP1\u2013637G and immunoproteasome PSMB9\u201360H variants influence the risk of developing vitiligo in the Saudi population. Dis Markers 260732","DOI":"10.1155\/2014\/260732"},{"key":"3_CR78","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s00580-012-1508-4","volume":"5","author":"NN Elmongy","year":"2013","unstructured":"Elmongy NN, Khalil REA (2013) PTPN22 gene polymorphism in Egyptian females with non-segmental vitiligo. Comp Clin Path 5:961\u2013964","journal-title":"Comp Clin Path"},{"key":"3_CR79","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s002510050250","volume":"2","author":"J Eskdale","year":"1997","unstructured":"Eskdale J, Kube D, Tesch H, Gallagher G (1997) Mapping of the human IL10 gene and further characterization of the 5\u2019 flanking sequence. Immunogenetics 2:120\u2013128","journal-title":"Immunogenetics"},{"key":"3_CR82","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1086\/375451","volume":"6","author":"PR Fain","year":"2003","unstructured":"Fain PR, Gowan K, LaBerge GS, Alkhateeb A, Stetler GL et al (2003) A genomewide screen for generalized vitiligo: confirmation of AIS1 on chromosome 1p31 and evidence for additional susceptibility loci. Am J Hum Genet 6:1560\u20131564","journal-title":"Am J Hum Genet"},{"key":"3_CR83","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1600-0749.2005.00279.x","volume":"1","author":"PR Fain","year":"2006","unstructured":"Fain PR, Babu SR, Bennett DC, Spritz RA (2006) HLA class II haplotype DRB1*04-DQB1*0301 contributes to risk of familial generalized vitiligo and early disease onset. Pigment Cell Res 1:51\u201357","journal-title":"Pigment Cell Res"},{"key":"3_CR84","doi-asserted-by":"publisher","first-page":"5252","DOI":"10.1038\/onc.2014.445","volume":"41","author":"LC Fan","year":"2015","unstructured":"Fan LC, Shiau CW, Tai WT, Hung MH, Chu PY et al (2015) SHP-1 is a negative regulator of epithelial-mesenchymal transition in hepatocellular carcinoma. Oncogene 41:5252\u20135263","journal-title":"Oncogene"},{"key":"3_CR85","first-page":"97","volume":"2","author":"MJ Fatahi","year":"2005","unstructured":"Fatahi MJ, Pezeshki A, Emad M, Lohrasb MH, Shamseddin A et al (2005) Lack of association between CTLA-4 A49G polymorphism and vitiligo. Iran J Immunol 2:97\u2013102","journal-title":"Iran J Immunol"},{"key":"3_CR86","doi-asserted-by":"crossref","unstructured":"Fernando MMA, Stevens CR, Walsh EC, De Jager PL, Goyette P et al (2008) Defining the role of the MHC in autoimmunity: a review and pooled analysis. PLoS Genet 4:e1000024","DOI":"10.1371\/journal.pgen.1000024"},{"key":"3_CR87","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1038\/jid.2013.5","volume":"6","author":"Ferrara TM, Jin Y, Gowan K, Fain PR","year":"2013","unstructured":"Ferrara TM, Jin Y, Gowan K, Fain PR, Spritz RA (2013) Risk of generalized vitiligo is associated with the common 55R\u201394A-247H variant haplotype of GZMB (encoding granzyme B). J Invest Dermatol 6:1677\u20131679","journal-title":"J Invest Dermatol"},{"key":"3_CR88","first-page":"48","volume":"1","author":"Finco O, Cuccia M, Martinetti M, Ru","year":"1991","unstructured":"Finco O, Cuccia M, Martinetti M, Ruberto G, Orecchia G et al (1991) Age of onset in vitiligo: relationship with HLA supratypes. Clin Genet 1:48\u201354","journal-title":"Clin Genet"},{"key":"3_CR89","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1002\/1521-4141(200010)30:10<2888::AID-IMMU2888>3.0.CO;2-4","volume":"10","author":"N F\u00f6ger","year":"2000","unstructured":"F\u00f6ger N, Marhaba R, Z\u00f6ller M (2000) CD44 supports T cell proliferation and apoptosis by apposition of protein kinases. Eur J Immunol 10:2888\u20132899","journal-title":"Eur J Immunol"},{"key":"3_CR90","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0190-9622(83)80279-5","volume":"1","author":"LM Foley","year":"1983","unstructured":"Foley LM, Lowe NJ, Misheloff E, Tiwari JL (1983) Association of HLA-DR4 with vitiligo. J Am Acad Dermatol 1:39\u201340","journal-title":"J Am Acad Dermatol"},{"key":"3_CR91","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1111\/j.1600-6143.2004.00566.x","volume":"10","author":"S Fu","year":"2004","unstructured":"Fu S, Zhang N, Yopp AC, Chen D, Mao M et al (2004) TGF-\u03b2 induces Foxp3 + T-regulatory cells from CD4 + CD25\u2014precursors. Am J Transplant 10:1614\u20131627","journal-title":"Am J Transplant"},{"key":"3_CR92","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.3892\/etm.2014.1975","volume":"5","author":"ME Garcia-Melendez","year":"2014","unstructured":"Garcia-Melendez ME, Salinas-Santander M, Sanchez-Dominguez C, Gonzalez-Cardenas H, Cerda-Flores RM et al (2014) Protein tyrosine phosphatase PTPN22 +1858C\/T polymorphism is associated with active vitiligo. Exp Ther Med 5:1433\u20131437","journal-title":"Exp Ther Med"},{"key":"3_CR93","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1158\/1541-7786.MCR-08-0021","volume":"1","author":"MG Gartside","year":"2009","unstructured":"Gartside MG, Chen H, Ibrahimi OA, Byron SA, Curtis AV et al (2009) Loss-of-function fibroblast growth factor receptor-2 mutations in melanoma. Mol Cancer Res 1:41\u201354","journal-title":"Mol Cancer Res"},{"key":"3_CR94","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1034\/j.1600-0749.2003.00070.x","volume":"4","author":"Y Gauthier","year":"2003","unstructured":"Gauthier Y, Cario Andre M, Ta\u00efeb A (2003) A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy? Pigment Cell Res 4:322\u2013332","journal-title":"Pigment Cell Res"},{"key":"3_CR95","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/j.1600-0625.2008.00813.x","volume":"5","author":"NG Gavalas","year":"2009","unstructured":"Gavalas NG, Gottumukkala RV, Gawkrodger DJ, Watson PF, Weetman AP et al (2009) Mapping of melanin-concentrating hormone receptor 1 B cell epitopes predicts two major binding sites for vitiligo patient autoantibodies. Exp Dermatol 5:454\u2013463","journal-title":"Exp Dermatol"},{"key":"3_CR98","doi-asserted-by":"crossref","unstructured":"Giri PS, Begum R, Dwivedi M (2022) Meta-analysis for association of TNFA -308 G>A polymorphism with vitiligo susceptibility. Gene 809:146027. https:\/\/doi.org\/10.1016\/j.gene.2021.146027","DOI":"10.1016\/j.gene.2021.146027"},{"key":"3_CR96","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/pcmr.12862","volume":"4","author":"PS Giri","year":"2020","unstructured":"Giri PS, Dwivedi M, Laddha NC, Begum R, Bharti AH (2020a) Altered expression of nuclear factor of activated T cells, forkhead box P3, and immune-suppressive genes in regulatory T cells of generalized vitiligo patients. Pigment Cell Melanoma Res 4:566\u2013578","journal-title":"Pigment Cell Melanoma Res"},{"key":"3_CR97","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1111\/exd.14157","volume":"8","author":"PS Giri","year":"2020","unstructured":"Giri PS, Dwivedi M, Begum R (2020b) Decreased suppression of CD8+ and CD4+ T cells by peripheral regulatory T cells in generalized vitiligo due to reduced NFATC1 and FOXP3 proteins. Exp Dermatol 8:759\u2013775","journal-title":"Exp Dermatol"},{"key":"3_CR99","doi-asserted-by":"crossref","unstructured":"Giri PS, Patel S, Begum R, Dwivedi M (2021) Association of FOXP3 and GAGE10 promoter polymorphisms and decreased FOXP3 expression in regulatory T cells with susceptibility to generalized vitiligo in Gujarat population. Gene 768:145295. https:\/\/doi.org\/10.1016\/j.gene.2020.145295","DOI":"10.1016\/j.gene.2020.145295"},{"key":"3_CR100","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1042\/CS20090603","volume":"3","author":"SJ Glassman","year":"2011","unstructured":"Glassman SJ (2011) Vitiligo, reactive oxygen species and T-cells. Clin Sci 3:99\u2013120","journal-title":"Clin Sci"},{"key":"3_CR101","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S0300-9084(01)01251-2","volume":"3\u20134","author":"M Groettrup","year":"2001","unstructured":"Groettrup M, Khan S, Schwarz K, Schmidtke G (2001) Interferon-gamma inducible exchanges of 20S proteasome active site subunits: why? Biochimie 3\u20134:367\u2013372","journal-title":"Biochimie"},{"key":"3_CR102","doi-asserted-by":"publisher","first-page":"451","DOI":"10.2174\/138920010791526105","volume":"5","author":"L Guerra","year":"2010","unstructured":"Guerra L, Dellambra E, Brescia S, Raskovic D (2010) Vitiligo: pathogenetic hypotheses and targets for current therapies. Curr Drug Metab 5:451\u2013467","journal-title":"Curr Drug Metab"},{"key":"3_CR103","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2340\/0001555563249251","volume":"3","author":"M Hafez","year":"1983","unstructured":"Hafez M, Sharaf L, Abd el-Nabi SM (1983) The genetics of vitiligo. Acta Derm Venereol 3:249\u2013251","journal-title":"Acta Derm Venereol"},{"key":"3_CR104","first-page":"406","volume":"6","author":"J Han","year":"2016","unstructured":"Han J, Liu J, Bai Y (2016) Association of single nucleotide polymorphisms in the IL2RA-RBM17 region with vitiligo in the Chinese Mongolian population. Chinese J Dermatol 6:406\u2013410","journal-title":"Chinese J Dermatol"},{"key":"3_CR105","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1073\/pnas.1525001113","volume":"5","author":"M Hayashi","year":"2016","unstructured":"Hayashi M, Jin Y, Yorgov D, Santorico SA, Hagman J et al (2016) Autoimmune vitiligo is associated with gain-of-function by a transcriptional regulator that elevates expression of HLA-A*02:01 in vivo. Proc Natl Acad Sci USA 5:1357\u20131362","journal-title":"Proc Natl Acad Sci USA"},{"key":"3_CR106","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/exd.12369","volume":"4","author":"RA Hegazy","year":"2014","unstructured":"Hegazy RA, Fawzy MM, Gawdat HI, Samir N, Rashed LA (2014) T helper 17 and Tregs: a novel proposed mechanism for NB-UVB in vitiligo. Exp Dermatol 4:283\u2013286","journal-title":"Exp Dermatol"},{"key":"3_CR107","doi-asserted-by":"crossref","unstructured":"Hirschhorn JN, Gajdos ZKZ (2011) Genome-wide association studies: results from the first few years and potential implications for clinical medicine. Annu Rev Med 11\u201324","DOI":"10.1146\/annurev.med.091708.162036"},{"key":"3_CR108","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/j.1346-8138.1997.tb02292.x","volume":"9","author":"Y Honda","year":"1997","unstructured":"Honda Y, Okubo Y, Koga M (1997) Relationship between levels of soluble interleukin-2 receptors and the types and activity of vitiligo. J Dermatol 9:561\u2013563","journal-title":"J Dermatol"},{"key":"3_CR109","doi-asserted-by":"crossref","unstructured":"Huraib GB, Al Harthi F, Arfin M, Aljamal A, Alrawi AS et al (2020) Association of functional polymorphism in protein tyrosine phosphatase nonreceptor 22 (PTPN22) gene with vitiligo. Biomark Insights 1177271920903038","DOI":"10.1177\/1177271920903038"},{"key":"3_CR110","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1164\/ajrccm.165.2.2106004","volume":"2","author":"B Hutyrov\u00e1","year":"2002","unstructured":"Hutyrov\u00e1 B, Pantelidis P, Dr\u00e1bek J, Z\u016frkov\u00e1 M, Kolek V et al (2002) Interleukin-1 gene cluster polymorphisms in sarcoidosis and idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2:148\u2013151","journal-title":"Am J Respir Crit Care Med"},{"key":"3_CR111","doi-asserted-by":"crossref","unstructured":"Ie A, M K-\u00d6, A G, P V, S D-A, et al (2015) The combination of tumour necrosis factor-\u03b1 -308A and interleukin-10-1082G gene polymorphisms and increased serum levels of related cytokines: susceptibility to vitiligo. Clin Exp Dermatol 1:71\u201377","DOI":"10.1111\/ced.12446"},{"key":"3_CR112","doi-asserted-by":"crossref","unstructured":"Imran M, Laddha NC, Dwivedi M, Mansuri MS, Singh J et al (2012) Interleukin-4 genetic variants correlate with its transcript and protein levels in patients with vitiligo. Br J Dermatol 2:314\u2013323","DOI":"10.1111\/j.1365-2133.2012.11000.x"},{"key":"3_CR113","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jdermsci.2005.03.003","volume":"3","author":"G Itirli","year":"2005","unstructured":"Itirli G, Pehlivan M, Alper S, Y\u00fcksel SE, Onay H et al (2005) Exon-3 polymorphism of CTLA-4 gene in Turkish patients with vitiligo. J Dermatol Sci 3:225\u2013227","journal-title":"J Dermatol Sci"},{"key":"3_CR114","doi-asserted-by":"crossref","unstructured":"Jadeja SD, Mansuri MS, Singh M, Dwivedi M, Laddha NC et al (2017) A case-control study on association of proteasome subunit beta 8 (PSMB8) and transporter associated with antigen processing 1 (TAP1) polymorphisms and their transcript levels in vitiligo from Gujarat. PLoS One 7:e0180958","DOI":"10.1371\/journal.pone.0180958"},{"key":"3_CR115","first-page":"262","volume":"2","author":"Jahan P, Cheruvu R, Tippisetty S, K","year":"2013","unstructured":"Jahan P, Cheruvu R, Tippisetty S, Komaravalli PL, Valluri V et al (2013) Association of FOXP3 (rs3761548) promoter polymorphism with nondermatomal vitiligo: A study from India. J Am Acad Dermatol 2:262\u2013266","journal-title":"J Am Acad Dermatol"},{"key":"3_CR116","first-page":"913","volume":"4","author":"S Jia","year":"2007","unstructured":"Jia S, Meng A (2007) Tob genes in development and homeostasis. Dev Dyn an off Publ Am Assoc Anat 4:913\u2013921","journal-title":"Dev Dyn an off Publ Am Assoc Anat"},{"key":"3_CR117","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1046\/j.1600-0749.2003.00105.x","volume":"1","author":"SY Jin","year":"2004","unstructured":"Jin SY, Park HH, Li GZ, Lee HJ, Hong MS et al (2004a) Association of angiotensin converting enzyme gene I\/D polymorphism of vitiligo in Korean population. Pigment Cell Res 1:84\u201386","journal-title":"Pigment Cell Res"},{"key":"3_CR118","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jdermsci.2004.06.008","volume":"3","author":"SY Jin","year":"2004","unstructured":"Jin SY, Park HH, Li GZ, Lee HJ, Hong MS et al (2004b) Association of estrogen receptor 1 intron 1 C\/T polymorphism in Korean vitiligo patients. J Dermatol Sci 3:181\u2013186","journal-title":"J Dermatol Sci"},{"key":"3_CR119","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1056\/NEJMoa061592","volume":"12","author":"Y Jin","year":"2007","unstructured":"Jin Y, Mailloux CM, Gowan K, Riccardi SL, LaBerge G et al (2007a) NALP1 in vitiligo-associated multiple autoimmune disease. N Engl J Med 12:1216\u20131225","journal-title":"N Engl J Med"},{"key":"3_CR120","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1600-0749.2007.00398.x","volume":"5","author":"Y Jin","year":"2007","unstructured":"Jin Y, Bennett DC, Amadi-Myers A, Holland P, Riccardi SL et al (2007b) Vitiligo-associated multiple autoimmune disease is not associated with genetic variation in AIRE. Pigment Cell Res 5:402\u2013404","journal-title":"Pigment Cell Res"},{"key":"3_CR131","doi-asserted-by":"crossref","unstructured":"Jin Y, Birlea SA, Fain PR, Spritz RA (2007c) Genetic variations in NALP1 are associated with generalized vitiligo in a Romanian population. J Invest Dermatol 11:2558\u20132562","DOI":"10.1038\/sj.jid.5700953"},{"key":"3_CR121","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/jid.2009.273","volume":"3","author":"Y Jin","year":"2010","unstructured":"Jin Y, Riccardi SL, Gowan K, Fain PR, Spritz RA (2010a) Fine-mapping of vitiligo susceptibility loci on chromosomes 7 and 9 and interactions with NLRP1 (NALP1). J Invest Dermatol 3:774\u2013783","journal-title":"J Invest Dermatol"},{"key":"3_CR122","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/ng.602","volume":"7","author":"Y Jin","year":"2010","unstructured":"Jin Y, Birlea SA, Fain PR, Mailloux CM, Riccardi SL et al (2010b) Common variants in FOXP1 are associated with generalized vitiligo. Nat Genet 7:576\u2013578","journal-title":"Nat Genet"},{"key":"3_CR123","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1056\/NEJMoa0908547","volume":"18","author":"Y Jin","year":"2010","unstructured":"Jin Y, Birlea SA, Fain PR, Gowan K, Riccardi SL et al (2010c) Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo. N Engl J Med 18:1686\u20131697","journal-title":"N Engl J Med"},{"key":"3_CR124","first-page":"137","volume":"3","author":"Y Jin","year":"2011","unstructured":"Jin Y, Xu A, Wang P, Song X, Liu X (2011a) Long-term follow-up and correlated factors of vitiligo following autologous epidermal transplantation. Cutis 3:137\u2013141","journal-title":"Cutis"},{"key":"3_CR125","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1038\/jid.2011.12","volume":"6","author":"Y Jin","year":"2011","unstructured":"Jin Y, Birlea SA, Fain PR, Gowan K, Riccardi SL et al (2011b) Genome-wide analysis identifies a quantitative trait locus in the MHC class II region associated with generalized vitiligo age of onset. J Invest Dermatol 6:1308\u20131312","journal-title":"J Invest Dermatol"},{"key":"3_CR126","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1038\/jid.2012.37","volume":"6","author":"Y Jin","year":"2012","unstructured":"Jin Y, Ferrara T, Gowan K, Holcomb C, Rastrou M et al (2012a) Next-generation DNA re-sequencing identifies common variants of TYR and HLA-A that modulate the risk of generalized vitiligo via antigen presentation. J Invest Dermatol 6:1730\u20131733","journal-title":"J Invest Dermatol"},{"key":"3_CR127","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/ng.2272","volume":"6","author":"Y Jin","year":"2012","unstructured":"Jin Y, Birlea SA, Fain PR, Ferrara TM, Ben S et al (2012b) Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo. Nat Genet 6:676\u2013680","journal-title":"Nat Genet"},{"key":"3_CR128","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/pcmr.12356","volume":"3","author":"Y Jin","year":"2015","unstructured":"Jin Y, Hayashi M, Fain PR, Suzuki T, Fukai K et al (2015) Major association of vitiligo with HLA-A*02:01 in Japanese. Pigment Cell Melanoma Res 3:360\u2013362","journal-title":"Pigment Cell Melanoma Res"},{"key":"3_CR130","doi-asserted-by":"crossref","unstructured":"Jin Y, Andersen G, Yorgov D, Ferrara TM, Ben S (2016) Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants. Nat Genet 11:1418\u20131424","DOI":"10.1038\/ng.3680"},{"key":"3_CR129","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41467-019-08337-4","volume":"1","author":"Y Jin","year":"2019","unstructured":"Jin Y, Roberts GHL, Ferrara TM, Ben S, van Geel N et al (2019) Early-onset autoimmune vitiligo associated with an enhancer variant haplotype that upregulates class II HLA expression. Nat Commun 1:391","journal-title":"Nat Commun"},{"key":"3_CR133","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.4049\/jimmunol.178.3.1433","volume":"3","author":"A Joetham","year":"2007","unstructured":"Joetham A, Takeda K, Taube C, Miyahara N, Matsubara S et al (2007) Naturally occurring lung CD4(+)CD25(+) T cell regulation of airway allergic responses depends on IL-10 induction of TGF-beta. J Immunol 3:1433\u20131442","journal-title":"J Immunol"},{"key":"3_CR134","doi-asserted-by":"publisher","first-page":"208","DOI":"10.2174\/187152809788680994","volume":"3","author":"P Johnson","year":"2009","unstructured":"Johnson P, Ruffell B (2009) CD44 and its role in inflammation and inflammatory diseases. Inflamm Allergy Drug Targets 3:208\u2013220","journal-title":"Inflamm Allergy Drug Targets"},{"key":"3_CR135","first-page":"1073","volume":"12","author":"C Ka","year":"2009","unstructured":"Ka C, Sc C, Ys K, Hb K, Ht C et al (2009) Association of thymic stromal lymphopoietin gene -847C>T polymorphism in generalized vitiligo. Exp Dermatol 12:1073\u20131075","journal-title":"Exp Dermatol"},{"key":"3_CR136","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/j.1399-0039.1978.tb01349.x","volume":"5","author":"RB Kachru","year":"1978","unstructured":"Kachru RB, Telischi M, Mittal KK (1978) HLA antigens and vitiligo in an American black population. Tissue Antigens 5:396\u2013397","journal-title":"Tissue Antigens"},{"key":"3_CR137","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s12519-009-0050-1","volume":"4","author":"Kakourou T","year":"2009","unstructured":"Kakourou T (2009) Vitiligo in children. World J Pediatr 4:265\u2013268","journal-title":"World J Pediatr"},{"key":"3_CR138","first-page":"2","volume":"157","author":"X Kang","year":"2017","unstructured":"Kang X, Liang J, Chai L, Peng L, Yu S (2017) Association of HLA-DRB1* 1201\/02, DRB1* 0701\/02, DQA1* 0302 and DQB1* 0303 Alleles with population Uygur patients of vitiligo. Clon Transgen 157:2","journal-title":"Clon Transgen"},{"key":"3_CR139","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1139\/bcb-2016-0228","volume":"4","author":"RA Karam","year":"2017","unstructured":"Karam RA, Zidan HE, Khater MH (2017) Genetic variants of interferon-gamma and its mRNA expression and inflammatory parameters in the pathogenesis of vitiligo. Biochem Cell Biol 4:474\u2013481","journal-title":"Biochem Cell Biol"},{"key":"3_CR140","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1080\/09723757.2015.11886257","volume":"3","author":"M Karkucak","year":"2015","unstructured":"Karkucak M, Solak B, Turan H, Uslu E, Yakut T et al (2015) MBL2 gene polymorphism and risk of vitiligo in Turkish patients. Int J Hum Genet 3:93\u201396","journal-title":"Int J Hum Genet"},{"key":"3_CR141","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature04734","volume":"7089","author":"H Kato","year":"2006","unstructured":"Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M et al (2006) Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 7089:101\u2013105","journal-title":"Nature"},{"key":"3_CR142","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/sj.cdd.4401179","volume":"1","author":"MM Kavurma","year":"2003","unstructured":"Kavurma MM, Khachigian LM (2003) Signaling and transcriptional control of Fas ligand gene expression. Cell Death Differ 1:36\u201344","journal-title":"Cell Death Differ"},{"key":"3_CR143","first-page":"333","volume":"3","author":"EH Kemp","year":"1998","unstructured":"Kemp EH, Gawkrodger DJ, Watson PF, Weetman AP (1998) Autoantibodies to human melanocyte-specific protein Pmel17 in the sera of vitiligo patients: a sensitive and quantitative radioimmunoassay (RIA). Clin Exp Immunol 3:333\u2013338","journal-title":"Clin Exp Immunol"},{"key":"3_CR144","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S0190-9622(96)90112-7","volume":"6","author":"Kent G, Al-Abadie M","year":"1996","unstructured":"Kent G, Al-Abadie M (1996) Psychologic effects of vitiligo: a critical incident analysis. J Am Acad Dermatol 6:895\u2013898","journal-title":"J Am Acad Dermatol"},{"key":"3_CR145","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.jaad.2011.07.018","volume":"3","author":"R Khan","year":"2012","unstructured":"Khan R, Gupta S, Sharma A (2012) Circulatory levels of T-cell cytokines (interleukin [IL]-2, IL-4, IL-17, and transforming growth factor-\u03b2) in patients with vitiligo. J Am Acad Dermatol 3:510\u2013511","journal-title":"J Am Acad Dermatol"},{"key":"3_CR146","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1038\/jid.2010.99","volume":"9","author":"NH Kim","year":"2010","unstructured":"Kim NH, Lee AY (2010) Reduced aquaporin3 expression and survival of keratinocytes in the depigmented epidermis of vitiligo. J Invest Dermatol 9:2231\u20132239","journal-title":"J Invest Dermatol"},{"key":"3_CR147","doi-asserted-by":"publisher","first-page":"7631","DOI":"10.4049\/jimmunol.0804308","volume":"12","author":"J Kim","year":"2009","unstructured":"Kim J, Lahl K, Hori S, Loddenkemper C, Chaudhry A et al (2009) Cutting edge: depletion of Foxp3 + cells leads to induction of autoimmunity by specific ablation of regulatory T cells in genetically targeted mice. J Immunol 12:7631\u20137634","journal-title":"J Immunol"},{"key":"3_CR148","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jdermsci.2006.08.001","volume":"2","author":"K Kingo","year":"2006","unstructured":"Kingo K, Philips MA, Aunin E, Luuk H, Karelson M et al (2006) MYG1, novel melanocyte related gene, has elevated expression in vitiligo. J Dermatol Sci 2:119\u2013122","journal-title":"J Dermatol Sci"},{"key":"3_CR149","doi-asserted-by":"publisher","first-page":"6606","DOI":"10.4049\/jimmunol.165.11.6606","volume":"11","author":"T Kouki","year":"2000","unstructured":"Kouki T, Sawai Y, Gardine CA, Fisfalen ME, Alegre ML et al (2000) CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves\u2019 disease. J Immunol 11:6606\u20136611","journal-title":"J Immunol"},{"key":"3_CR150","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/j.1365-3083.2004.01444.x","volume":"6","author":"OP Kristiansen","year":"2004","unstructured":"Kristiansen OP, Karlsen AE, Larsen ZM, Johannesen J, Pociot F et al (2004) Identification of a type 1 diabetes-associated CD4 promoter haplotype with high constitutive activity. Scand J Immunol 6:582\u2013591","journal-title":"Scand J Immunol"},{"key":"3_CR151","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1111\/j.1365-4632.2011.05377.x","volume":"10","author":"C Kr\u00fcger","year":"2012","unstructured":"Kr\u00fcger C, Schallreuter KU (2012) A review of the worldwide prevalence of vitiligo in children\/adolescents and adults. Int J Dermatol 10:1206\u20131212","journal-title":"Int J Dermatol"},{"key":"3_CR152","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s10858-014-9819-1","volume":"3","author":"H Kumeta","year":"2014","unstructured":"Kumeta H, Sakakibara H, Enokizono Y, Ogura K, Horiuchi M et al (2014) The N-terminal domain of TIR domain-containing adaptor molecule-1, TICAM-1. J Biomol NMR 3:227\u2013230","journal-title":"J Biomol NMR"},{"key":"3_CR153","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/j.1600-0749.2005.00242.x","volume":"4","author":"G Laberge","year":"2005","unstructured":"Laberge G, Mailloux CM, Gowan K, Holland P, Bennett DC et al (2005) Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo. Pigment Cell Res 4:300\u2013305","journal-title":"Pigment Cell Res"},{"key":"3_CR154","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1755-148X.2008.00443.x","volume":"2","author":"GS Laberge","year":"2008","unstructured":"Laberge GS, Birlea SA, Fain PR, Spritz RA (2008) The PTPN22-1858C>T (R620W) functional polymorphism is associated with generalized vitiligo in the Romanian population. Pigment Cell Melanoma Res 2:206\u2013208","journal-title":"Pigment Cell Melanoma Res"},{"key":"3_CR155","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1038\/sj.jid.5701233","volume":"7","author":"GS LaBerge","year":"2008","unstructured":"LaBerge GS, Bennett DC, Fain PR, Spritz RA (2008) PTPN22 is genetically associated with risk of generalized vitiligo, but CTLA4 is not. J Invest Dermatol 7:1757\u20131762","journal-title":"J Invest Dermatol"},{"key":"3_CR160","doi-asserted-by":"crossref","unstructured":"Laddha NC, Dwivedi M, Begum R (2002) Vitiligo: a manifestation of apoptosis? Am J Clin Dermatol 5:301\u2013308","DOI":"10.2165\/00128071-200203050-00001"},{"key":"3_CR156","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jdermsci.2007.10.002","volume":"3","author":"NC Laddha","year":"2008","unstructured":"Laddha NC, Dwivedi M, Shajil EM, Prajapati H, Marfatia YS et al (2008) Association of PTPN22 1858C\/T polymorphism with vitiligo susceptibility in Gujarat population. J Dermatol Sci 3:260\u2013262","journal-title":"J Dermatol Sci"},{"key":"3_CR158","unstructured":"Laddha NC, Dwivedi M, Begum R, Shahbaz ANS, Namazi RSM et al (2012) Tumor necrosis factor a promotor polymorphism and nonsegmental vitiligo: a molecular susceptibility marker in Egyptian women. PLoS One 1\u201317"},{"key":"3_CR157","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/exd.12103","volume":"4","author":"NC Laddha","year":"2013","unstructured":"Laddha NC, Dwivedi M, Mansuri MS, Gani AR, Ansarullah M et al (2013) Vitiligo: Interplay between oxidative stress and immune system. Exp Dermatol 4:245\u2013250","journal-title":"Exp Dermatol"},{"key":"3_CR159","doi-asserted-by":"crossref","unstructured":"Laddha NC, Dwivedi M, Mansuri MS, Singh M, Patel HH et al (2014) Association of neuropeptide Y (NPY), interleukin-1B (IL1B) genetic variants and correlation of IL1B transcript levels with vitiligo susceptibility. PLoS One 9","DOI":"10.1371\/journal.pone.0107020"},{"key":"3_CR161","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.biocel.2009.09.013","volume":"1","author":"M Lamkanfi","year":"2010","unstructured":"Lamkanfi M, Kanneganti T-D (2010) Caspase-7: a protease involved in apoptosis and inflammation. Int J Biochem Cell Biol 1:21\u201324","journal-title":"Int J Biochem Cell Biol"},{"key":"3_CR162","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.immuni.2006.01.005","volume":"2","author":"M Le Borgne","year":"2006","unstructured":"Le Borgne M, Etchart N, Goubier A, Lira SA, Sirard JC et al (2006) Dendritic cells rapidly recruited into epithelial tissues via CCR6\/CCL20 are responsible for CD8+ T cell crosspriming in vivo. Immunity 2:191\u2013201","journal-title":"Immunity"},{"key":"3_CR163","doi-asserted-by":"crossref","unstructured":"Le Poole IC, Luiten RM (2008) Autoimmune etiology of generalized vitiligo. Curr Dir Autoimmun 227\u2013243","DOI":"10.1159\/000131485"},{"key":"3_CR164","doi-asserted-by":"crossref","unstructured":"Le Poole IC, Sarangarajan R, Zhao Y, Stennett LS, Brown TL et al (2001) \u201cVIT1\u201d, a novel gene associated with vitiligo. Pigment Cell Res 6:475\u2013484","DOI":"10.1034\/j.1600-0749.2001.140608.x"},{"key":"3_CR165","doi-asserted-by":"publisher","first-page":"5548","DOI":"10.4238\/2015.May.25.6","volume":"2","author":"YH Lee","year":"2015","unstructured":"Lee YH, Bae SC (2015) Associations between TNF-\u03b1 polymorphisms and susceptibility to rheumatoid arthritis and vitiligo: a meta-analysis. Genet Mol Res 2:5548\u20135559","journal-title":"Genet Mol Res"},{"key":"3_CR166","first-page":"285","volume":"2","author":"Lernerab AB","year":"1959","unstructured":"Lernerab AB (1959) Vitiligo. J Invest Dermatol 2. Part 2:285\u2013310","journal-title":"Part"},{"key":"3_CR167","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1001\/archderm.1958.01560090080017","volume":"3","author":"Levai M","year":"1958","unstructured":"Levai M (1958) A study of certain contributory factors in the development of vitiligo in South Indian patients. AMA Arch Derm 3:364\u2013371","journal-title":"AMA Arch Derm"},{"key":"3_CR168","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1073\/pnas.1222808110","volume":"8","author":"CB Levandowski","year":"2013","unstructured":"Levandowski CB, Mailloux CM, Ferrara TM, Gowan K, Ben S et al (2013) NLRP1 haplotypes associated with vitiligo and autoimmunity increase interleukin-1\u03b2 processing via the NLRP1 inflammasome. Proc Natl Acad Sci USA 8:2952\u20132956","journal-title":"Proc Natl Acad Sci USA"},{"key":"3_CR169","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1038\/jid.2008.161","volume":"12","author":"M Li","year":"2008","unstructured":"Li M, Sun D, Li C, Zhang Z, Gao L et al (2008) Functional polymorphisms of the FAS gene associated with risk of vitiligo in Chinese populations: a case-control analysis. J Invest Dermatol 12:2820\u20132824","journal-title":"J Invest Dermatol"},{"key":"3_CR170","doi-asserted-by":"crossref","unstructured":"Li Z, Ren J, Niu X, Xu Q, Wang X et al (2016) Meta-analysis of the association between vitiligo and human leukocyte antigen-A. Biomed Res Int 5412806","DOI":"10.1155\/2016\/5412806"},{"key":"3_CR171","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1038\/sj.jid.5700904","volume":"11","author":"Y Liang","year":"2007","unstructured":"Liang Y, Yang S, Zhou Y, Gui J, Ren Y et al (2007) Evidence for two susceptibility loci on chromosomes 22q12 and 6p21-p22 in Chinese generalized vitiligo families. J Invest Dermatol 11:2552\u20132557","journal-title":"J Invest Dermatol"},{"key":"3_CR172","doi-asserted-by":"crossref","unstructured":"Liou H-C, Boothby MR, Finn PW, Davidon R, Nabavi N et al (1990) A new member of the leucine zipper class of proteins that binds to the HLA DR alpha promoter. Science (80\u2013) 4950:1581\u20131584","DOI":"10.1126\/science.2321018"},{"key":"3_CR80","doi-asserted-by":"crossref","unstructured":"Lili Y, Yi W, Ji Y, Yue S, Weimin S (2012) Global activation of CD8+ cytotoxic T lymphocytes correlates with an impairment in regulatory T cells in patients with generalized vitiligo. PLoS One 5","DOI":"10.1371\/journal.pone.0037513"},{"key":"3_CR173","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/ni906","volume":"4","author":"A Liston","year":"2003","unstructured":"Liston A, Lesage S, Wilson J, Peltonen L, Goodnow CC (2003) Aire regulates negative selection of organ-specific T cells. Nat Immunol 4:350\u2013354","journal-title":"Nat Immunol"},{"key":"3_CR174","first-page":"205","volume":"2","author":"JB Liu","year":"2007","unstructured":"Liu JB, Li M, Chen H, Zhong SQ, Yang S et al (2007) Association of vitiligo with HLA-A2: a meta-analysis. J Eur Acad Dermatol Venereol 2:205\u2013213","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3_CR175","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1111\/j.1468-3083.2011.04259.x","volume":"9","author":"J Liu","year":"2012","unstructured":"Liu J, Tang H, Zuo X, Liang B, Wang P et al (2012) A single nucleotide polymorphism rs9468925 of MHC region is associated with clinical features of generalized vitiligo in Chinese Han population. J Eur Acad Dermatol Venereol 9:1137\u20131141","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3_CR176","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3109\/08916939209035163","volume":"4","author":"R Lorini","year":"1992","unstructured":"Lorini R, Orecchia G, Martinetti M, Dugoujon JM, Cuccia M (1992) Autoimmunity in vitiligo: relationship with HLA, Gm and Km polymorphisms. Autoimmunity 4:255\u2013260","journal-title":"Autoimmunity"},{"key":"3_CR177","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00403-013-1315-z","volume":"5","author":"Y Lv","year":"2013","unstructured":"Lv Y, Lv Y, Li Q, Lei W, Luan Q et al (2013) Association of ACE gene I\/D polymorphism with vitiligo: a meta-analysis. Arch Dermatol Res 5:365\u2013370","journal-title":"Arch Dermatol Res"},{"key":"3_CR178","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1001\/archderm.1977.01640110035002","volume":"11","author":"C Macaron","year":"1977","unstructured":"Macaron C, Winter RJ, Traisman HS, Kahan BD, Lasser AE et al (1977) Vitiligo and juvenile diabetes mellitus. Arch Dermatol 11:1515\u20131517","journal-title":"Arch Dermatol"},{"key":"3_CR179","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1016\/j.yexcr.2008.05.020","volume":"13","author":"S Maier","year":"2008","unstructured":"Maier S, Paulsson M, Hartmann U (2008) The widely expressed extracellular matrix protein SMOC-2 promotes keratinocyte attachment and migration. Exp Cell Res 13:2477\u20132487","journal-title":"Exp Cell Res"},{"key":"3_CR180","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1001\/archderm.1993.01680290066010","volume":"8","author":"PP Majumder","year":"1993","unstructured":"Majumder PP, Nordlund JJ, Nath SK (1993) Pattern of familial aggregation of vitiligo. Arch Dermatol 8:994\u2013998","journal-title":"Arch Dermatol"},{"key":"3_CR181","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1046\/j.1432-1327.1998.2550139.x","volume":"1","author":"Mart\u00ednez\u2010Esparza M, Jim\u00e9nez\u2010Cervant","year":"1998","unstructured":"Mart\u00ednez\u2010Esparza M, Jim\u00e9nez\u2010Cervantes C, Solano F, Lozano JA, Garc\u00eda\u2010Borr\u00f3n JC (1998) Mechanisms of melanogenesis inhibition by tumor necrosis factor-alpha in B16\/F10 mouse melanoma cells. Eur J Biochem 1:139\u2013146","journal-title":"Eur J Biochem"},{"key":"3_CR182","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","volume":"2","author":"F Martinon","year":"2002","unstructured":"Martinon F, Burns K, Tschopp J (2002) The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-\u03b2. Mol Cell 2:417\u2013426","journal-title":"Mol Cell"},{"key":"3_CR183","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1159\/000250480","volume":"2","author":"A Metzker","year":"1980","unstructured":"Metzker A, Zamir R, Gazit E, David M, Feuerman EJ (1980) Vitiligo and the HLA system. Dermatologica 2:100\u2013105","journal-title":"Dermatologica"},{"key":"3_CR184","first-page":"41","volume":"5","author":"M Minev","year":"1985","unstructured":"Minev M, Tonkin N, Martinova F (1985) Association of the HLA system with vitiligo. Vestn Dermatol Venerol 5:41\u201342","journal-title":"Vestn Dermatol Venerol"},{"key":"3_CR185","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1093\/rheumatology\/41.5.518","volume":"5","author":"K Miyake","year":"2002","unstructured":"Miyake K, Nakashima H, Akahoshi M, Inoue Y, Nagano S et al (2002) Genetically determined interferon-gamma production influences the histological phenotype of lupus nephritis. Rheumatol 5:518\u2013524","journal-title":"Rheumatol"},{"key":"3_CR186","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/1523-1747.ep12500086","volume":"5","author":"G Moellmann","year":"1982","unstructured":"Moellmann G, Klein-Angerer S, Scollay DA, Nordlund JJ, Lerner AB (1982) Extracellular granular material and degeneration of keratinocytes in the normally pigmented epidermis of patients with vitiligo. J Invest Dermatol 5:321\u2013330","journal-title":"J Invest Dermatol"},{"key":"3_CR187","first-page":"252","volume":"3","author":"J Mohr","year":"1951","unstructured":"Mohr J (1951) Vitiligo in a pair of monovular twins. Acta Genet Stat Med 3:252\u2013255","journal-title":"Acta Genet Stat Med"},{"key":"3_CR188","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.ajhg.2008.09.013","volume":"4","author":"V Molho-Pessach","year":"2008","unstructured":"Molho-Pessach V, Lerer I, Abeliovich D, Agha Z, Libdeh AA et al (2008) The H syndrome is caused by mutations in the nucleoside transporter hENT3. Am J Hum Genet 4:529\u2013534","journal-title":"Am J Hum Genet"},{"key":"3_CR189","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1001\/archderm.138.2.273","volume":"2","author":"S Moretti","year":"2002","unstructured":"Moretti S, Spallanzani A, Amato L, Hautmann G, Gallerani I et al (2002) Vitiligo and epidermal microenvironment: Possible involvement of keratinocyte-derived cytokines. Arch Dermatol 2:273\u2013274","journal-title":"Arch Dermatol"},{"key":"3_CR190","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/j.1755-148X.2011.00916.x","volume":"1","author":"JA Mosenson","year":"2012","unstructured":"Mosenson JA, Zloza A, Klarquist J, Barfuss AJ, Guevara-Patino JA et al (2012) HSP70i is a critical component of the immune response leading to vitiligo. Pigment Cell Melanoma Res 1:88\u201398","journal-title":"Pigment Cell Melanoma Res"},{"key":"3_CR191","first-page":"939","volume":"10","author":"H Nakagawa","year":"1980","unstructured":"Nakagawa H, Otuka F, Kukita A, Mizoguchi M, Ito H et al (1980) Histocompatible antigens in vitiligo vulgaris II (author\u2019s transl). Nihon Hifuka Gakkai Zasshi 10:939\u2013941","journal-title":"Nihon Hifuka Gakkai Zasshi"},{"key":"3_CR192","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/sj.gene.6363830","volume":"2","author":"Nakashima H, Miyake K, Inoue Y, Shi","year":"2002","unstructured":"Nakashima H, Miyake K, Inoue Y, Shimizu S, Akahoshi M et al (2002) Association between IL-4 genotype and IL-4 production in the Japanese population. Genes Immun 2:107\u2013109","journal-title":"Genes Immun"},{"key":"3_CR193","first-page":"21","volume":"1","author":"Namian AM, Shahbaz S, Salmanpoor R,","year":"2009","unstructured":"Namian AM, Shahbaz S, Salmanpoor R, Namazi MR, Dehghani F et al (2009) Association of interferon-gamma and tumor necrosis factor alpha polymorphisms with susceptibility to vitiligo in Iranian patients. Arch Dermatol Res 1:21\u201325","journal-title":"Arch Dermatol Res"},{"key":"3_CR194","first-page":"981","volume":"5","author":"SK Nath","year":"1994","unstructured":"Nath SK, Majumder PP, Nordlund JJ (1994) Genetic epidemiology of vitiligo: multilocus recessivity cross-validated. Am J Hum Genet 5:981\u2013990","journal-title":"Am J Hum Genet"},{"key":"3_CR195","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1086\/324470","volume":"6","author":"SK Nath","year":"2001","unstructured":"Nath SK, Kelly JA, Namjou B, Lam T, Bruner GR et al (2001) Evidence for a susceptibility gene, SLEV1, on chromosome 17p13 in families with vitiligo-related systemic lupus erythematosus. Am J Hum Genet 6:1401\u20131406","journal-title":"Am J Hum Genet"},{"key":"3_CR197","doi-asserted-by":"crossref","unstructured":"Naughton GK, Reggiardo D, Bystryn JC (1986) Correlation between vitiligo antibodies and extent of depigmentation in vitiligo. J Am Acad Dermatol 5(Pt 1):978\u2013981","DOI":"10.1016\/S0190-9622(86)70260-0"},{"key":"3_CR198","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1084\/jem.157.3.1020","volume":"3","author":"SL Naylor","year":"1983","unstructured":"Naylor SL, Sakaguchi AY, Shows TB, Law ML, Goeddel DV et al (1983) Human immune interferon gene is located on chromosome 12. J Exp Med 3:1020\u20131027","journal-title":"J Exp Med"},{"key":"3_CR199","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3923\/pjbs.2013.570.574","volume":"12","author":"SB Nejad","year":"2013","unstructured":"Nejad SB, Qadim HH, Nazeman L, Fadaii R, Goldust M (2013) Frequency of autoimmune diseases in those suffering from vitiligo in comparison with normal population. Pak J Biol Sci 12:570\u2013574","journal-title":"Pak J Biol Sci"},{"key":"3_CR200","doi-asserted-by":"publisher","first-page":"17296","DOI":"10.4238\/2015.December.16.30","volume":"4","author":"G Nie","year":"2015","unstructured":"Nie G, Qi JH, Huang CW, Yang T, Shi N et al (2015) Meta-analysis of the TNF-\u03b1-308G\/A polymorphism and vitiligo risk. Genet Mol Res 4:17296\u201317304","journal-title":"Genet Mol Res"},{"key":"3_CR202","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1001\/archderm.1982.01650130009007","volume":"1","author":"JJ Nordlund","year":"1982","unstructured":"Nordlund JJ, Lerner AB (1982) Vitiligo. It is important. Arch Dermatol 1:5\u20138","journal-title":"Arch Dermatol"},{"key":"3_CR201","doi-asserted-by":"crossref","unstructured":"Nordlund JJ, Boissy RE, Hearing VJ, King RA, Oetting WS et al (2007) The pigmentary system: physiology and pathophysiology, 2nd edn. Pigment Syst Physiol Pathophysiol Second Ed 1\u20131229","DOI":"10.1002\/9780470987100"},{"key":"3_CR203","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1600-0749.1994.tb00049.x","volume":"4","author":"DA Norris","year":"1994","unstructured":"Norris DA, Horikawa T, Morelli JG (1994) Melanocyte destruction and repopulation in vitiligo. Pigment Cell Res 4:193\u2013203","journal-title":"Pigment Cell Res"},{"key":"3_CR204","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1172\/JCI23215","volume":"10","author":"O\u2019Garra A, Vieira PL, Vieira P, Gol","year":"2004","unstructured":"O\u2019Garra A, Vieira PL, Vieira P, Goldfeld AE (2004) IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage. J Clin Invest 10:1372\u20131378","journal-title":"J Clin Invest"},{"key":"3_CR205","doi-asserted-by":"publisher","first-page":"935","DOI":"10.7326\/0003-4819-71-5-935","volume":"5","author":"Y Ochi","year":"1969","unstructured":"Ochi Y, DeGroot LJ (1969) Vitiligo in Graves\u2019 disease. Ann Intern Med 5:935\u2013940","journal-title":"Ann Intern Med"},{"key":"3_CR206","first-page":"1","volume":"1","author":"AMA Odeh","year":"2019","unstructured":"Odeh AMA, Bulatova NR, Yousef AF (2019) Genetic Association of TNF-alpha polymorphisms with generalized vitiligo in Jordanian population. J Genet Disord Genet Med 1:1\u20134","journal-title":"J Genet Disord Genet Med"},{"key":"3_CR207","first-page":"146","volume":"2","author":"H Onay","year":"2007","unstructured":"Onay H, Pehlivan M, Alper S, Ozkinay F, Pehlivan S (2007) Might there be a link between mannose binding lectin and vitiligo? Eur J Dermatol 2:146\u2013148","journal-title":"Eur J Dermatol"},{"key":"3_CR208","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1159\/000084751","volume":"4","author":"K Ongenae","year":"2005","unstructured":"Ongenae K, Dierckxsens L, Brochez L, van Geel N, Naeyaert JM (2005) Quality of life and stigmatization profile in a cohort of vitiligo patients and effect of the use of camouflage. Dermatology 4:279\u2013285","journal-title":"Dermatology"},{"key":"3_CR209","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000247426","volume":"2","author":"G Orecchia","year":"1992","unstructured":"Orecchia G, Perfetti L, Malagoli P, Borghini F, Kipervarg Y (1992) Vitiligo is associated with a significant increase in HLA-A30, Cw6 and DQw3 and a decrease in C4AQ0 in northern Italian patients. Dermatology 2:123\u2013127","journal-title":"Dermatology"},{"key":"3_CR210","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1600-0749.1993.tb00584.x","volume":"2","author":"JP Ortonne","year":"1993","unstructured":"Ortonne JP, Bose SK (1993) Vitiligo: where do we stand? Pigment Cell Res 2:61\u201372","journal-title":"Pigment Cell Res"},{"key":"3_CR211","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/ni886","volume":"2","author":"H Oshiumi","year":"2003","unstructured":"Oshiumi H, Matsumoto M, Funami K, Akazawa T, Seya T (2003) TICAM-1, an adaptor molecule that participates in Toll-like receptor 3\u2013mediated interferon-\u03b2 induction. Nat Immunol 2:161\u2013167","journal-title":"Nat Immunol"},{"key":"3_CR212","doi-asserted-by":"publisher","first-page":"276","DOI":"10.47102\/annals-acadmedsg.V38N3p276","volume":"3","author":"JY Pan","year":"2009","unstructured":"Pan JY, Theng C, Lee J, Goh BK (2009) Vitiligo as an adverse reaction to topical diphencyprone. Ann Acad Med Singap 3:276\u2013277","journal-title":"Ann Acad Med Singap"},{"key":"3_CR213","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1046\/j.1365-2796.2000.00575.x","volume":"1","author":"KI Papadopoulos","year":"2000","unstructured":"Papadopoulos KI, Melander O, Orho-Melander M, Groop LC, Carlsson M et al (2000) Angiotensin converting enzyme (ACE) gene polymorphism in sarcoidosis in relation to associated autoimmune diseases. J Intern Med 1:71\u201377","journal-title":"J Intern Med"},{"key":"3_CR214","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1111\/bjd.12177","volume":"6","author":"M Patwardhan","year":"2013","unstructured":"Patwardhan M, Pradhan V, Taylor LH, Thakkar V, Kharkar V et al (2013) The angiotensin-converting enzyme gene insertion\/deletion polymorphism in Indian patients with vitiligo: a case-control study and meta-analysis. Br J Dermatol 6:1195\u20131204","journal-title":"Br J Dermatol"},{"key":"3_CR215","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/286617a0","volume":"5773","author":"J Pawelek","year":"1980","unstructured":"Pawelek J, K\u00f6rner A, Bergstrom A, Bologna J (1980) New regulators of melanin biosynthesis and the autodestruction of melanoma cells. Nature 5773:617\u2013619","journal-title":"Nature"},{"key":"3_CR216","doi-asserted-by":"publisher","first-page":"21181","DOI":"10.1074\/jbc.270.36.21181","volume":"36","author":"RJ Peach","year":"1995","unstructured":"Peach RJ, Bajorath J, Naemura J, Leytze G, Greene J et al (1995) Both extracellular immunoglobin-like domains of CD80 contain residues critical for binding T cell surface receptors CTLA-4 and CD28. J Biol Chem 36:21181\u201321187","journal-title":"J Biol Chem"},{"key":"3_CR217","first-page":"126","volume":"2","author":"S Pehlivan","year":"2009","unstructured":"Pehlivan S, Ozkinay F, Alper S, Onay H, Yuksel E et al (2009) Association between IL4 (-590), ACE (I)\/(D), CCR5 (Delta32), CTLA4 (+49) and IL1-RN (VNTR in intron 2) gene polymorphisms and vitiligo. Eur J Dermatol 2:126\u2013128","journal-title":"Eur J Dermatol"},{"key":"3_CR218","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1038\/nri2450","volume":"12","author":"P Peterson","year":"2008","unstructured":"Peterson P, Org T, Rebane A (2008) Transcriptional regulation by AIRE: molecular mechanisms of central tolerance. Nat Rev Immunol 12:948\u2013957","journal-title":"Nat Rev Immunol"},{"key":"3_CR219","doi-asserted-by":"crossref","unstructured":"Philips MA, Kingo K, Karelson M, R\u00e4tsep R, Aunin E et al (2010) Promoter polymorphism-119C\/G in MYG1 (C12orf10) gene is related to vitiligo susceptibility and Arg4Gln affects mitochondrial entrance of Myg1. BMC Med Genet 11:56","DOI":"10.1186\/1471-2350-11-56"},{"key":"3_CR220","first-page":"59","volume":"1","author":"Poloy A, Tibor L, Kramer J, Anh-Tua","year":"1991","unstructured":"Poloy A, Tibor L, Kramer J, Anh-Tuan N, Kraszits E et al (1991) HLA-DR1 is associated with vitiligo. Immunol Lett 1:59\u201362","journal-title":"Immunol Lett"},{"key":"3_CR221","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1365-2370.1999.00122.x","volume":"1","author":"V Pravica","year":"1999","unstructured":"Pravica V, Asderakis A, Perrey C, Hajeer A, Sinnott PJ et al (1999) In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. Eur J Immunogenet 1:1\u20133","journal-title":"Eur J Immunogenet"},{"key":"3_CR222","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/S0198-8859(00)00167-1","volume":"9","author":"V Pravica","year":"2000","unstructured":"Pravica V, Perrey C, Stevens A, Lee JH, Hutchinson IV (2000) A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum Immunol 9:863\u2013866","journal-title":"Hum Immunol"},{"key":"3_CR223","doi-asserted-by":"crossref","unstructured":"Qi Z, Xie S, Chen R, Aisa HA, Hon GC et al (2018) Tissue-specific gene expression prediction associates vitiligo with SUOX through an active enhancer. bioRxiv: 337196","DOI":"10.1101\/337196"},{"key":"3_CR224","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/ng.603","volume":"7","author":"C Quan","year":"2010","unstructured":"Quan C, Ren YQ, Xiang LH, Sun LD, Xu AE et al (2010) Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC. Nat Genet 7:614\u2013618","journal-title":"Nat Genet"},{"key":"3_CR225","doi-asserted-by":"publisher","first-page":"280","DOI":"10.5114\/ada.2018.76225","volume":"3","author":"KS Rajendiran","year":"2018","unstructured":"Rajendiran KS, Rajappa M, Chandrashekar L, Thappa DM (2018) Association of PTPN22 gene polymorphism with non-segmental vitiligo in South Indian Tamils. Postep Dermatol Alergol 3:280\u2013285","journal-title":"Postep Dermatol Alergol"},{"key":"3_CR226","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1159\/000505544","volume":"6","author":"KS Rajendiran","year":"2020","unstructured":"Rajendiran KS, Rajappa M, Chandrashekar L, Thappa DM, Devaraju P (2020) Association analysis of tumor necrosis factor alpha promoter polymorphisms and vitiligo susceptibility in South Indian Tamils. Dermatology 6:554\u2013564","journal-title":"Dermatology"},{"key":"3_CR227","doi-asserted-by":"publisher","first-page":"e347","DOI":"10.1111\/ijd.13194","volume":"6","author":"LD Ramire","year":"2016","unstructured":"Ramire LD, Marcos EV, Godoy DA, de Souza-Santana FC (2016) Association of class I and II HLA alleles and haplotypes with susceptibility to vitiligo: a study of patients with vitiligo from southeast Brazil. Int J Dermatol 6:e347\u2013e355","journal-title":"Int J Dermatol"},{"key":"3_CR228","doi-asserted-by":"crossref","unstructured":"Rashed L, Abdel Hay R, Mahmoud R, Hasan N, Zahra A et al (2015) Association of angiotensin-converting enzyme (ACE) gene polymorphism with inflammation and cellular cytotoxicity in vitiligo patients. PLoS One 7:e0132915","DOI":"10.1371\/journal.pone.0132915"},{"key":"3_CR229","doi-asserted-by":"crossref","unstructured":"Ren Y, Yang S, Xu S, Gao M, Huang W et al (2009) Genetic variation of promoter sequence modulates XBP1 expression and genetic risk for vitiligo. PLoS Genet 6:e1000523","DOI":"10.1371\/journal.pgen.1000523"},{"key":"3_CR230","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1365-2133.1976.tb00822.x","volume":"2","author":"G Retornaz","year":"1976","unstructured":"Retornaz G, Betuel H, Ortonne JP, Thivolet J (1976) HL-A antigens and vitiligo. Br J Dermatol 2:173\u2013175","journal-title":"Br J Dermatol"},{"key":"3_CR231","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/j.1600-0625.2012.01473.x","volume":"6","author":"AS Ricard","year":"2012","unstructured":"Ricard AS, Pain C, Daubos A, Ezzedine K, Lamrissi-Garcia I et al (2012) Study of CCN3 (NOV) and DDR1 in normal melanocytes and vitiligo skin. Exp Dermatol 6:411\u2013416","journal-title":"Exp Dermatol"},{"key":"3_CR232","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1172\/JCI114844","volume":"4","author":"B Rigat","year":"1990","unstructured":"Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P et al (1990) An insertion\/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 4:1343\u20131346","journal-title":"J Clin Invest"},{"key":"3_CR233","unstructured":"Rina W (2016) Association of single nucleotide polymorphisms in the IL2RA-RBM17 region with vitiligo in the Chinese Mongolian population. Chiense J Dermatol 6:406\u2013410"},{"key":"3_CR234","doi-asserted-by":"publisher","first-page":"22855","DOI":"10.1074\/jbc.M513463200","volume":"32","author":"EF Rocnik","year":"2006","unstructured":"Rocnik EF, Liu P, Sato K, Walsh K, Vaziri C (2006) The novel SPARC family member SMOC-2 potentiates angiogenic growth factor activity. J Biol Chem 32:22855\u201322864","journal-title":"J Biol Chem"},{"key":"3_CR235","unstructured":"Rodriguez-Castro KI, Franceschi M, Miraglia C, Russo M, Nouvenne A et al (2018) Autoimmune diseases in autoimmune atrophic gastritis. Acta Biomed 8-s:100\u2013103"},{"key":"3_CR236","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/01.EWX.0000443903.37427.6c","volume":"2","author":"NF Saleh","year":"2014","unstructured":"Saleh NF, Nabil N, Bassiouny DA, Khorshied MM (2014) Tumor necrosis factor \u03b1 promotor polymorphism and nonsegmental vitiligo: a molecular susceptibility marker in Egyptian women. J Egypt Women\u2019s Dermatol Soc 2:109\u2013112","journal-title":"J Egypt Women\u2019s Dermatol Soc"},{"key":"3_CR237","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3892\/etm.2012.508","volume":"5","author":"M Salinas-Santander","year":"2012","unstructured":"Salinas-Santander M, D\u00edaz-Garc\u00eda D, Rojas-Mart\u00ednez A, Cant\u00fa-Salinas C, S\u00e1nchez-Dom\u00ednguez C et al (2012) Tumor necrosis factor-\u03b1-308G\/A polymorphism is associated with active vitiligo vulgaris in a northeastern Mexican population. Exp Ther Med 5:893\u2013897","journal-title":"Exp Ther Med"},{"key":"3_CR239","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.1038\/sj.onc.1203716","volume":"33","author":"S Sasaki","year":"2000","unstructured":"Sasaki S, Ito E, Toki T, Maekawa T, Kanezaki R et al (2000) Cloning and expression of human B cell-specific transcription factor BACH2 mapped to chromosome 6q15. Oncogene 33:3739\u20133749","journal-title":"Oncogene"},{"key":"3_CR240","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1111\/1523-1747.ep12492612","volume":"6","author":"KU Schallreuter","year":"1991","unstructured":"Schallreuter KU, Wood JM, Berger J (1991) Low catalase levels in the epidermis of patients with vitiligo. J Invest Dermatol 6:1081\u20131085","journal-title":"J Invest Dermatol"},{"key":"3_CR241","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1159\/000247240","volume":"3","author":"KU Schallreuter","year":"1993","unstructured":"Schallreuter KU, Levenig C, K\u00fchnl P, L\u00f6liger C, Hohl-Tehari M et al (1993) Histocompatibility antigens in vitiligo: Hamburg study on 102 patients from northern Germany. Dermatology 3:186\u2013192","journal-title":"Dermatology"},{"key":"3_CR242","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1159\/000247164","volume":"4","author":"KU Schallreuter","year":"1994","unstructured":"Schallreuter KU, Lemke R, Brandt O, Schwartz R, Westhofen M et al (1994) Vitiligo and other diseases: coexistence or true association? Hamburg study on 321 patients. Dermatology 4:269\u2013275","journal-title":"Dermatology"},{"key":"3_CR243","doi-asserted-by":"publisher","first-page":"3866","DOI":"10.4049\/jimmunol.170.7.3866","volume":"7","author":"TE Scholzen","year":"2003","unstructured":"Scholzen TE, St\u00e4nder S, Riemann H, Brzoska T, Luger TA (2003) Modulation of cutaneous inflammation by angiotensin-converting enzyme. J Immunol 7:3866\u20133873","journal-title":"J Immunol"},{"key":"3_CR244","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S1359-6101(03)00049-2","volume":"5","author":"E Schutyser","year":"2003","unstructured":"Schutyser E, Struyf S, Van Damme J (2003) The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev 5:409\u2013426","journal-title":"Cytokine Growth Factor Rev"},{"key":"3_CR245","doi-asserted-by":"crossref","unstructured":"Shah F, Patel S, Begum R, Dwivedi M (2021) Emerging role of tissue resident memory T cells in vitiligo: from pathogenesis to therapeutics. Autoimmun Rev 8","DOI":"10.1016\/j.autrev.2021.102868"},{"key":"3_CR246","first-page":"526","volume":"7","author":"EM Shajil","year":"2006","unstructured":"Shajil EM, Chatterjee S, Agrawal D, Bagchi T, Begum R (2006) Vitiligo: pathomechanisms and genetic polymorphism of susceptible genes. Indian J Exp Biol 7:526\u2013539","journal-title":"Indian J Exp Biol"},{"key":"3_CR247","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0163-7258(00)00096-6","volume":"3","author":"K Sharma","year":"2000","unstructured":"Sharma K, Wang RX, Zhang LY, Yin DL, Luo XY et al (2000) Death the Fas way: regulation and pathophysiology of CD95 and its ligand. Pharmacol Ther 3:333\u2013347","journal-title":"Pharmacol Ther"},{"key":"3_CR248","doi-asserted-by":"publisher","first-page":"14467","DOI":"10.1073\/pnas.97.26.14467","volume":"26","author":"HD Shin","year":"2000","unstructured":"Shin HD, Winkler C, Stephens JC, Bream J, Young H et al (2000) Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10. Proc Natl Acad Sci USA 26:14467\u201314472","journal-title":"Proc Natl Acad Sci USA"},{"key":"3_CR249","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.3892\/etm.2011.326","volume":"6","author":"MK Shin","year":"2011","unstructured":"Shin MK, Im SH, Park HJ, Kim SK, Yim SV et al (2011) Association study between polymorphisms of CD28, CTLA4 and ICOS and non-segmental vitiligo in a Korean population. Exp Ther Med 6:1145\u20131149","journal-title":"Exp Ther Med"},{"key":"3_CR250","first-page":"436","volume":"21","author":"E Sidi","year":"1953","unstructured":"Sidi E, Bourgeois-Gavardin J (1953) Treatment of vitiligo with Ammi majus. Press Med 21:436\u2013440","journal-title":"Press Med"},{"key":"3_CR251","first-page":"2449","volume":"38","author":"HW Siemens","year":"1953","unstructured":"Siemens HW (1953) Heredity problem in vitiligo. Ned Tijdschr Geneeskd 38:2449\u20132450","journal-title":"Ned Tijdschr Geneeskd"},{"key":"3_CR252","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/ng1204-1248","volume":"12","author":"KA Siminovitch","year":"2004","unstructured":"Siminovitch KA (2004) PTPN22 and autoimmune disease. Nat Genet 12:1248\u20131249","journal-title":"Nat Genet"},{"key":"3_CR253","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/jid.2011.240","volume":"1","author":"A Singh","year":"2012","unstructured":"Singh A, Sharma P, Kar HK, Sharma VK, Tembhre MK et al (2012) HLA alleles and amino-acid signatures of the peptide-binding pockets of HLA molecules in vitiligo. J Invest Dermatol 1:124\u2013134","journal-title":"J Invest Dermatol"},{"key":"3_CR254","first-page":"285","volume":"3","author":"M Singh","year":"2018","unstructured":"Singh M, Mansuri MS, Jadeja SD, Marfatia YS, Begum R (2018) Association of interleukin 1 receptor antagonist intron 2 variable number of tandem repeats polymorphism with vitiligo susceptibility in Gujarat population. Indian J Dermatol Venereol Leprol 3:285\u2013291","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"3_CR255","first-page":"25","volume":"1","author":"Q-H Song","year":"2012","unstructured":"Song Q-H, Shen Z, Xing X-J, Yin R, Wu Y-Z et al (2012) An association study of single nucleotide polymorphisms of the FOXP3 intron-1 and the risk of Psoriasis vulgaris. Indian J Biochem Biophys 1:25\u201335","journal-title":"Indian J Biochem Biophys"},{"key":"3_CR256","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/bjd.12377","volume":"3","author":"P Song","year":"2013","unstructured":"Song P, Wang XW, Li HX, Li K, Liu L et al (2013) Association between FOXP3 polymorphisms and vitiligo in a Han Chinese population. Br J Dermatol 3:571\u2013578","journal-title":"Br J Dermatol"},{"key":"3_CR257","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1177\/1470320313478285","volume":"1","author":"GG Song","year":"2015","unstructured":"Song GG, Bae SC, Kim JH, Lee YH (2015) The angiotensin-converting enzyme insertion\/deletion polymorphism and susceptibility to rheumatoid arthritis, vitiligo and psoriasis: a meta-analysis. J Renin Angiotensin Aldosterone Syst 1:195\u2013202","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"3_CR258","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000236329","volume":"1","author":"H Spits","year":"1992","unstructured":"Spits H, de Waal MR (1992) Functional characterization of human IL-10. Int Arch Allergy Immunol 1:8\u201315","journal-title":"Int Arch Allergy Immunol"},{"key":"3_CR259","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1600-0749.2007.00384.x","volume":"4","author":"RA Spritz","year":"2007","unstructured":"Spritz RA (2007) The genetics of generalized vitiligo and associated autoimmune diseases. Pigment Cell Res 4:271\u2013278","journal-title":"Pigment Cell Res"},{"key":"3_CR265","doi-asserted-by":"crossref","unstructured":"Spritz RA (2008) The genetics of generalized vitiligo. Curr Dir Autoimmun 244\u2013257","DOI":"10.1159\/000131501"},{"key":"3_CR260","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1089\/thy.2010.1643","volume":"7","author":"RA Spritz","year":"2010","unstructured":"Spritz RA (2010a) Shared genetic relationships underlying generalized vitiligo and autoimmune thyroid disease. Thyroid 7:745\u2013754","journal-title":"Thyroid"},{"key":"3_CR266","doi-asserted-by":"crossref","unstructured":"Spritz RA (2010b) The genetics of generalized vitiligo: autoimmune pathways and an inverse relationship with malignant melanoma. Genome Med 10.","DOI":"10.1186\/gm199"},{"key":"3_CR261","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jgg.2011.05.005","volume":"7","author":"RA Spritz","year":"2011","unstructured":"Spritz RA (2011) Recent progress in the genetics of generalized vitiligo. J Genet Genomics 7:271\u2013278","journal-title":"J Genet Genomics"},{"key":"3_CR262","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/jid.2011.321","volume":"2","author":"RA Spritz","year":"2012","unstructured":"Spritz RA (2012) Six decades of vitiligo genetics: genome-wide studies provide insights into autoimmune pathogenesis. J Invest Dermatol 2:268\u2013273","journal-title":"J Invest Dermatol"},{"key":"3_CR263","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.det.2016.11.013","volume":"2","author":"RA Spritz","year":"2017","unstructured":"Spritz RA, Andersen GHL (2017) Genetics of Vitiligo. Dermatol Clin 2:245\u2013255","journal-title":"Dermatol Clin"},{"key":"3_CR264","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1086\/381134","volume":"1","author":"RA Spritz","year":"2004","unstructured":"Spritz RA, Gowan K, Bennett DC, Fain PR (2004) Novel vitiligo susceptibility loci on chromosomes 7 (AIS2) and 8 (AIS3), confirmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis. Am J Hum Genet 1:188\u2013191","journal-title":"Am J Hum Genet"},{"key":"3_CR267","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1755-148X.2007.00429.x","volume":"2","author":"S Str\u00f6mberg","year":"2008","unstructured":"Str\u00f6mberg S, Bj\u00f6rklund MG, Asplund A, Rimini R, Lundeberg J et al (2008) Transcriptional profiling of melanocytes from patients with vitiligo vulgaris. Pigment Cell Melanoma Res 2:162\u2013171","journal-title":"Pigment Cell Melanoma Res"},{"key":"3_CR268","first-page":"451","volume":"11","author":"G Stuttgen","year":"1950","unstructured":"Stuttgen G (1950) Hereditary aspects of vitiligo. Z Haut Geschlechtskr 11:451\u2013457","journal-title":"Z Haut Geschlechtskr"},{"key":"3_CR269","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1136\/jmedgenet-2013-102233","volume":"5","author":"Y Sun","year":"2014","unstructured":"Sun Y, Zuo X, Zheng X, Zhou F, Liang B et al (2014) A comprehensive association analysis confirms ZMIZ1 to be a susceptibility gene for vitiligo in Chinese population. J Med Genet 5:345\u2013353","journal-title":"J Med Genet"},{"key":"3_CR270","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/j.1365-2133.2009.09217.x","volume":"3","author":"ZA Taher","year":"2009","unstructured":"Taher ZA, Lauzon G, Maguiness S, Dytoc MT (2009) Analysis of interleukin-10 levels in lesions of vitiligo following treatment with topical tacrolimus. Br J Dermatol 3:654\u2013659","journal-title":"Br J Dermatol"},{"key":"3_CR271","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1600-0749.2006.00355.x","volume":"1","author":"A Ta\u00efeb","year":"2007","unstructured":"Ta\u00efeb A, Picardo M (2007) The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res 1:27\u201335","journal-title":"Pigment Cell Res"},{"key":"3_CR272","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1056\/NEJMcp0804388","volume":"2","author":"A Ta\u00efeb","year":"2009","unstructured":"Ta\u00efeb A, Picardo M (2009) Clinical practice. Vitiligo. N Engl J Med 2:160\u2013169","journal-title":"N Engl J Med"},{"key":"3_CR273","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/jid.2012.320","volume":"2","author":"XF Tang","year":"2013","unstructured":"Tang XF, Zhang Z, Hu DY, Xu AE, Zhou HS et al (2013) Association analyses identify three susceptibility Loci for vitiligo in the Chinese Han population. J Invest Dermatol 2:403\u2013410","journal-title":"J Invest Dermatol"},{"key":"3_CR274","doi-asserted-by":"publisher","first-page":"11829","DOI":"10.18632\/aging.102452","volume":"24","author":"L Tang","year":"2019","unstructured":"Tang L, Li J, Fu W, Wu W, Xu J (2019) Suppression of FADS1 induces ROS generation, cell cycle arrest, and apoptosis in melanocytes: implications for vitiligo. Aging (albany NY) 24:11829\u201311843","journal-title":"Aging (albany NY)"},{"key":"3_CR275","first-page":"403","volume":"4","author":"JK Tarlow","year":"1993","unstructured":"Tarlow JK, Blakemore AI, Lennard A, Solari R, Hughes HN et al (1993) Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 4:403\u2013404","journal-title":"Hum Genet"},{"key":"3_CR276","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1600-0749.2004.00141.x","volume":"2","author":"HB Ta\u015ftan","year":"2004","unstructured":"Ta\u015ftan HB, Akar A, Orkuno\u011flu FE, Arca E, Inal A (2004) Association of HLA class I antigens and HLA class II alleles with vitiligo in a Turkish population. Pigment Cell Res 2:181\u2013184","journal-title":"Pigment Cell Res"},{"key":"3_CR277","first-page":"181","volume":"2","author":"Ta\u015ftan HB, Akar A, Orkuno\u011flu FE, Ar","year":"2004","unstructured":"Ta\u015ftan HB, Akar A, Orkuno\u011flu FE, Arca E, \u0130nal A (2004) Association of HLA class I antigens and HLA class II alleles with vitiligo in a Turkish population. Pigment Cell Res 2:181\u2013184","journal-title":"Pigment Cell Res"},{"key":"3_CR278","first-page":"591","volume":"3","author":"R Tazi-Ahnini","year":"2008","unstructured":"Tazi-Ahnini R, McDonagh AJ, Wengraf DA, Lovewell TR, Vasilopoulos Y et al (2008) The autoimmune regulator gene (AIRE) is strongly associated with vitiligo. Br J Dermatol 3:591\u2013596","journal-title":"Br J Dermatol"},{"key":"3_CR279","first-page":"457","volume":"11","author":"H Teindel","year":"1950","unstructured":"Teindel H (1950) Familial vitiligo. Z Haut Geschlechtskr 11:457\u2013462","journal-title":"Z Haut Geschlechtskr"},{"key":"3_CR280","doi-asserted-by":"crossref","unstructured":"Tembhre MK, Sharma VK, Sharma A, Chattopadhyay P, Gupta S (2013) T helper and regulatory T cell cytokine profile in active, stable and narrow band ultraviolet B treated generalized vitiligo. Clin Chim Acta 27\u201332","DOI":"10.1016\/j.cca.2013.05.005"},{"key":"3_CR281","doi-asserted-by":"crossref","unstructured":"The MHC Sequencing Consortium (1999) Complete sequence and gene map of a human major histocompatibility complex. Nature 6756:921\u2013923","DOI":"10.1038\/44853"},{"key":"3_CR282","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/j.1600-0749.2005.00269.x","volume":"5","author":"AC Theos","year":"2005","unstructured":"Theos AC, Truschel ST, Raposo G, Marks MS (2005) The Silver locus product Pmel17\/gp100\/Silv\/ME20: controversial in name and in function. Pigment Cell Res 5:322\u2013336","journal-title":"Pigment Cell Res"},{"key":"3_CR283","first-page":"173","volume":"2","author":"S Tippisetty","year":"2011","unstructured":"Tippisetty S, Ishaq M, Komaravalli PL, Jahan P (2011) Angiotensin converting enzyme (ACE) gene polymorphism in vitiligo: protective and predisposing effects of genotypes in disease susceptibility and progression. Eur J Dermatol 2:173\u2013177","journal-title":"Eur J Dermatol"},{"key":"3_CR284","first-page":"71","volume":"2","author":"MAK Toama","year":"2019","unstructured":"Toama MAK, Khattab FM, Marei A (2019) Association of human leukocyte antigen-DRB1 with the response in patients with vitiligo. Egypt J Dermatol Venerol 2:71","journal-title":"Egypt J Dermatol Venerol"},{"key":"3_CR285","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S0952-7915(03)00107-9","volume":"5","author":"JA Trapani","year":"2003","unstructured":"Trapani JA, Sutton VR (2003) Granzyme B: pro-apoptotic, antiviral and antitumor functions. Curr Opin Immunol 5:533\u2013543","journal-title":"Curr Opin Immunol"},{"key":"3_CR286","first-page":"103","volume":"2","author":"RK Tripathi","year":"1991","unstructured":"Tripathi RK, Giebel LB, Strunk KM, Spritz RA (1991) A polymorphism of the human tyrosinase gene is associated with temperature-sensitive enzymatic activity. Gene Expr J Liver Res 2:103\u2013110","journal-title":"Gene Expr J Liver Res"},{"key":"3_CR287","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.imlet.2011.01.002","volume":"1\u20132","author":"J Trowsdale","year":"2011","unstructured":"Trowsdale J (2011) The MHC, disease and selection. Immunol Lett 1\u20132:1\u20138","journal-title":"Immunol Lett"},{"key":"3_CR288","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nrm1019","volume":"2","author":"J Tschopp","year":"2003","unstructured":"Tschopp J, Martinon F, Burns K (2003) NALPs: a novel protein family involved in inflammation. Nat Rev Mol Cell Biol 2:95\u2013104","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3_CR289","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2370.1997.tb00001.x","volume":"1","author":"DM Turner","year":"1997","unstructured":"Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ et al (1997) An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1:1\u20138","journal-title":"Eur J Immunogenet"},{"key":"3_CR290","unstructured":"T\u00fcrsen \u00dc, Kaya T\u0130, Bulut B, Erdal ME, Ay \u00d6\u0130 et al (2014) Association of FAS gene promoter functional polymorphisms and the risk of vitiligo in Turkish populations. J Turkish Acad Dermatol 3"},{"key":"3_CR291","unstructured":"Valia AK, Dutta PK (1996) IADVL text book and atlas of dermatology, vol-II, and 2"},{"key":"3_CR292","first-page":"9","volume":"1","author":"R Valsecchi","year":"1995","unstructured":"Valsecchi R, Bontempelli M, Cainelli T, Leghissa P, Di Landro A (1995) Vitiligo is associated with a significant increase in HLA-DR6 and a decrease in DQw2 antigens in Northern Italian patients. J Eur Acad Dermatol Venereol 1:9\u201314","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3_CR293","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1038\/jid.2009.32","volume":"9","author":"JG van den Boorn","year":"2009","unstructured":"van den Boorn JG, Konijnenberg D, Dellemijn TAM, van der Veen JPW, Bos JD et al (2009) Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients. J Invest Dermatol 9:2220\u20132232","journal-title":"J Invest Dermatol"},{"key":"3_CR294","doi-asserted-by":"crossref","unstructured":"Veiga-Castelli L, Oliveira ML, Pereira A, Debortoli G, Marcorin L et al (2019) HLA-G polymorphisms are associated with non-segmental vitiligo among Brazilians. Biomolecules 9","DOI":"10.3390\/biom9090463"},{"key":"3_CR295","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1365-2230.1995.tb01279.x","volume":"1","author":"MN Venkataram","year":"1995","unstructured":"Venkataram MN, White AG, Leeny WA, Al Suwaid AR, Daar AS (1995) HLA antigens in Omani patients with vitiligo. Clin Exp Dermatol 1:35\u201337","journal-title":"Clin Exp Dermatol"},{"key":"3_CR296","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1111\/1523-1747.ep12614826","volume":"6","author":"GT Venneker","year":"1992","unstructured":"Venneker GT, Westerhof W, de Vries IJ, Drayer NM, Wolthers BG et al (1992) Molecular heterogeneity of the fourth component of complement (C4) and its genes in vitiligo. J Invest Dermatol 6:853\u2013858","journal-title":"J Invest Dermatol"},{"key":"3_CR297","first-page":"1","volume":"1","author":"F Vogel","year":"1956","unstructured":"Vogel F (1956) Dermatological observations on uniovular twins: vitiligo, ichthyosis simplex, psoriasis. Z Haut Geschlechtskr 1:1\u20134","journal-title":"Z Haut Geschlechtskr"},{"key":"3_CR298","doi-asserted-by":"crossref","unstructured":"Wang L, Tsai C-C (2008) Atrophin proteins: an overview of a new class of nuclear receptor corepressors. Nucl Recept Signal 1:nrs. 06009","DOI":"10.1621\/nrs.06009"},{"key":"3_CR299","unstructured":"Wang HN, Qi YM, Gao YF et al. Frequencies of HLA-A2 among patients with tumors, chronic hepatitis C and vitiligo in Henan Province. J Zhengzhou Univ Med Sci 3:349\u2013351"},{"key":"3_CR300","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1097\/01.LAB.0000069521.42488.1B","volume":"5","author":"A Wa\u0144kowicz-Kali\u0144ska","year":"2003","unstructured":"Wa\u0144kowicz-Kali\u0144ska A, van den Wijngaard RMJGJ, Tigges BJ, Westerhof W, Ogg GS et al (2003) Immunopolarization of CD4+ and CD8+ T cells to Type-1\u2013like is associated with melanocyte loss in human vitiligo. Lab Investig 5:683\u2013695","journal-title":"Lab Investig"},{"key":"3_CR301","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1600-0749.2007.00399.x","volume":"5","author":"W Westerhof","year":"2007","unstructured":"Westerhof W, d\u2019Ischia M (2007) Vitiligo puzzle: the pieces fall in place. Pigment Cell Res 5:345\u2013359","journal-title":"Pigment Cell Res"},{"key":"3_CR302","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.1093\/nar\/gkl409","volume":"10","author":"A Weston","year":"2006","unstructured":"Weston A, Sommerville J (2006) Xp54 and related (DDX6-like) RNA helicases: roles in messenger RNP assembly, translation regulation and RNA degradation. Nucleic Acids Res 10:3082\u20133094","journal-title":"Nucleic Acids Res"},{"key":"3_CR303","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1111\/j.0906-6705.2004.00221.x","volume":"12","author":"CS Wu","year":"2004","unstructured":"Wu CS, Yu CL, Wu CS, Lan CC, Yu HS (2004) Narrow-band ultraviolet-B stimulates proliferation and migration of cultured melanocytes. Exp Dermatol 12:755\u2013763","journal-title":"Exp Dermatol"},{"key":"3_CR304","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3892\/mmr.2012.1117","volume":"1","author":"J Wu","year":"2013","unstructured":"Wu J, Zhou M, Wan Y, Xu A (2013) CD8+ T cells from vitiligo perilesional margins induce autologous melanocyte apoptosis. Mol Med Rep 1:237\u2013241","journal-title":"Mol Med Rep"},{"key":"3_CR305","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1111\/ijd.12866","volume":"9","author":"D Wu","year":"2015","unstructured":"Wu D, Shi D, Zhu X (2015) The association between tumor necrosis factor-\u03b1-308 G\/A polymorphism and risk for vitiligo: a meta-analysis. Int J Dermatol 9:1045\u20131053","journal-title":"Int J Dermatol"},{"key":"3_CR306","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.4049\/jimmunol.181.4.2277","volume":"4","author":"S Xiao","year":"2008","unstructured":"Xiao S, Jin H, Korn T, Liu SM, Oukka M et al (2008) Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J Immunol 4:2277\u20132284","journal-title":"J Immunol"},{"key":"3_CR307","first-page":"123","volume":"2","author":"W Xu","year":"2013","unstructured":"Xu W, Lin FQ, Liu JF, Fu LF, Hong WS et al (2013) Impact on tyrosinase expression and export from endoplasmic reticulum by inhibition of 26S proteasome. Zhonghua Yi Xue Za Zhi 2:123\u2013127","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"3_CR308","doi-asserted-by":"publisher","first-page":"13001","DOI":"10.1038\/s41598-018-31233-8","volume":"1","author":"M Xu","year":"2018","unstructured":"Xu M, Liu Y, Liu Y, Li X, Chen G et al (2018) Genetic polymorphisms of GZMB and vitiligo: a genetic association study based on Chinese Han population. Sci Rep 1:13001","journal-title":"Sci Rep"},{"key":"3_CR309","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1093\/intimm\/dxh165","volume":"11","author":"H Yagi","year":"2004","unstructured":"Yagi H, Nomura T, Nakamura K, Yamazaki S, Kitawaki T et al (2004) Crucial role of FOXP3 in the development and function of human CD25+ CD4+ regulatory T cells. Int Immunol 11:1643\u20131656","journal-title":"Int Immunol"},{"key":"3_CR310","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1111\/j.1365-4632.2004.02389.x","volume":"12","author":"S Yang","year":"2005","unstructured":"Yang S, Wang J-Y, Gao M, Liu H-S, Sun L-D et al (2005) Association of HLA-DQA1 and DQB1 genes with vitiligo in Chinese Hans. Int J Dermatol 12:1022\u20131027","journal-title":"Int J Dermatol"},{"key":"3_CR311","first-page":"46","volume":"1","author":"Yazici AC, Erdal ME, Kaya TI, Ikizo","year":"2006","unstructured":"Yazici AC, Erdal ME, Kaya TI, Ikizoglu G, Savasoglu K et al (2006) Lack of association with TNF-alpha-308 promoter polymorphism in patients with vitiligo. Arch Dermatol Res 1:46\u201349","journal-title":"Arch Dermatol Res"},{"key":"3_CR312","first-page":"1","volume":"1","author":"SH Yildiz","year":"2016","unstructured":"Yildiz SH, Yildirim A, \u00d6zu\u011fuz P, Erdo\u011fan M\u00d6, Ka\u00e7ar SD et al (2016) 119C\/G in MYG1 gene and 49A\/G in CTLA4 gene polymorphisms in Turkish patients with vitiligo. J Adv Intern Med 1:1\u20135","journal-title":"J Adv Intern Med"},{"key":"3_CR313","first-page":"233","volume":"2","author":"Yohn JJ, Critelli M, Lyons MB, Norr","year":"1990","unstructured":"Yohn JJ, Critelli M, Lyons MB, Norris DA (1990) Modulation of melanocyte intercellular adhesion molecule-1 by immune cytokines. J Invest Dermatol 2:233\u2013237","journal-title":"J Invest Dermatol"},{"key":"3_CR314","doi-asserted-by":"crossref","unstructured":"Yun JY, Uhm YK, Kim HJ, Lim SH, Chung JH et al (2010) Transforming growth factor beta receptor II (TGFBR2) polymorphisms and the association with nonsegmental vitiligo in the Korean population. Int J Immunogenet 4:289\u2013291","DOI":"10.1111\/j.1744-313X.2010.00923.x"},{"key":"3_CR317","doi-asserted-by":"crossref","unstructured":"Zamani M, Spaepen S, Sghar SS, Huang C, Westerhof W et al (2001) Linkage and association of HLA class II genes with vitiligo in a Dutch population. Br J Dermatol 1:90\u201394","DOI":"10.1046\/j.1365-2133.2001.04288.x"},{"key":"3_CR316","first-page":"521","volume":"5","author":"M Zamani","year":"2010","unstructured":"Zamani M, Tabatabaiefar MA, Mosayyebi S, Mashaghi A, Mansouri P (2010) Possible association of the CD4 gene polymorphism with vitiligo in an Iranian population. Clin Exp Dermatol 5:521\u2013524","journal-title":"Clin Exp Dermatol"},{"key":"3_CR318","doi-asserted-by":"publisher","first-page":"3820","DOI":"10.1038\/onc.2017.26","volume":"27","author":"Z Zhai","year":"2017","unstructured":"Zhai Z, Liu W, Kaur M, Luo Y, Domenico J et al (2017) NLRP1 promotes tumor growth by enhancing inflammasome activation and suppressing apoptosis in metastatic melanoma. Oncogene 27:3820\u20133830","journal-title":"Oncogene"},{"key":"3_CR319","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jdermsci.2004.05.003","volume":"2","author":"XJ Zhang","year":"2004","unstructured":"Zhang XJ, Liu HS, Liang YH, Sun LD, Wang JY et al (2004) Association of HLA class I alleles with vitiligo in Chinese Hans. J Dermatol Sci 2:165\u2013168","journal-title":"J Dermatol Sci"},{"key":"3_CR320","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jdermsci.2005.06.004","volume":"3","author":"XJ Zhang","year":"2005","unstructured":"Zhang XJ, Chen JJ, Liu JB (2005) The genetic concept of vitiligo. J Dermatol Sci 3:137\u2013146","journal-title":"J Dermatol Sci"},{"key":"3_CR321","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/ni1455","volume":"5","author":"Y Zheng","year":"2007","unstructured":"Zheng Y, Rudensky AY (2007) Foxp3 in control of the regulatory T cell lineage. Nat Immunol 5:457\u2013462","journal-title":"Nat Immunol"},{"key":"3_CR322","doi-asserted-by":"crossref","unstructured":"Zhu KJ, Lv YM, Yin XY, Wang ZX, Sun LD et al (2011) Psoriasis regression analysis of MHC loci identifies shared genetic variants with vitiligo. PLoS One 11:e23089","DOI":"10.1371\/journal.pone.0023089"}],"container-title":["Advances in Experimental Medicine and Biology","The Immunogenetics of Dermatologic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-92616-8_3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T20:01:20Z","timestamp":1700337680000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-030-92616-8_3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9783030926151","9783030926168"],"references-count":318,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-92616-8_3","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"15 March 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This work was supported by grant to Dr. Mitesh Dwivedi {ECR\/2017\/000858} from Science and Engineering Research Board, Department of Science & Technology (SERB-DST), New Delhi.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding Sources"}}]}}